周围神经感觉束和运动束的比较蛋白质组学研究
|
摘要
目的：寻找周围神经感觉和运动束之间的特异或高差异蛋白,为周围神经感觉和运动束的鉴别和干预损伤修复的分子机制提供新思路；同时阐明周围神经感觉和运动束损伤后不同时间点蛋白量的变化,筛选对神经束再生修复具有重要作用的标志蛋白。
方法：通过对正常Wistar大鼠周围神经运动束和感觉束(股神经运动支和隐神经),在Sunderland V度损伤后8小时和8天分别在远侧断端切取5mm样本；6种样本共18组进行分离提取蛋白；蛋白质纯化及定量处理,应用差异凝胶电泳(DIGE)技术荧光标记各组蛋白质；凝胶图像扫描,用图像分析软件(DeCyder)全自动比较分析并识别各组间的差异表达蛋白质图谱；选择表达差异大于1.5倍的蛋白点；高差异蛋白点进行制备胶上自动切割、自动酶切、自动点靶,然后使用MALDI-TOF Pro质谱仪在反射场模式下进行肽质量指纹(PMF图谱)分析鉴定；应用Realtime-PCR技术分析比较蛋白质组学研究的结果。结果：应用2D-DIGE进行分离后,成功地获得了蛋白质组分辨率高、重复性好的荧光差异蛋白质图谱,用BVA软件分析显示9块凝胶平均分离1586个蛋白点。对于蛋白表达的统计学处理采用t检验。校准后选取在9块胶上均出现蛋白表达量上调或下调超过1.5倍、P<0.05的蛋白定义为高差异表达蛋白。本次发现实验组差异表达的蛋白共160个。最终选取16个高差异蛋白点分析鉴定,结果共有14个蛋白点被确切地鉴定。它们是：ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1、DPYSL2、CaBP1、HSP70、Gng 7、LDHB、Enolase2、Serpina 10、PDIA3。其中(1)周围神经感觉和运动束之间的高差异蛋白有：ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1。(2)与周围神经感觉束损伤后再生有关的高差异蛋白有：TPM1、DPYSL2、NF-L、Serpina 10、CaBPl。(3)与周围神经运动束损伤后再生有关的高差异蛋白有：Serpina3n、Peroxiredoxin-2、HSP70、LDHB、Enolase2、CaBP1、Serpina 10、Gng7、PDIA3。(4) ApoE在Y／G的比值是-1.94倍,匹配良好,蛋白稳定出现在所有胶中,T-test统计学数值是0.00068,具有统计学意义；8HY／8HG的比值是-2.07倍,匹配良好,蛋白稳定出现在所有胶中,T-test统计学数值是0.0053,具有统计学意义；8DY／8DG的比值是-2.20倍,匹配良好,蛋白稳定出现在所有胶中,T-test统计学数值是0.0069,具有统计学意义。ApoE在正常、Sunderland V度周围神经运动和感觉束(股神经运动支和隐神经)损伤后8小时远断端5mm和损伤后8天远断端5mm等三种时间点感觉束中含量是运动束的2倍左右,ApoE有望作为周围神经感觉和运动束的鉴别高差异标记蛋白。
结论：周围神经感觉束和运动束之间的比较蛋白质组学表达存在明显差异,这些差异蛋白质(ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1)为进一步阐明周围神经感觉束和运动束之间的生理功能差别以实现临床标记鉴别提供实验依据；筛选出对于周围神经感觉束和运动束在不同时间点的再生具有重要作用的蛋白(TPM1、Serpina 10、DPYSL2、NF-L、CaBP1、Serpina3n、Peroxiredoxin-2、HSP70、LDHB、Enolase2、Gng7、PDI A3),可利用这些蛋白在不同时间段的表达差异为临床周围神经再生干预提供新的研究手段。首次成功地把比较蛋白质组学应用于周围神经感觉束与运动束高差异标记物的筛选,现今国内外还没有应用比较蛋白质组学进行筛选周围神经感觉束与运动束不同时间点的差异蛋白的相关研究或报导；突破了传统的周围神经感觉束与运动束在单一时间点鉴别的观念；在探讨周围神经感觉束损伤后不同时间的蛋白质量的变化,和周围神经运动束损伤后不同时间的蛋白质量的变化上作了积极的工作。
Comparative proteomics reveals proteins expression differences between the motor and sensory fascicles of peripheral nerve
With high disability rate, the Peripheral Nerve (PN) injury has always troubled surgeons. PN injury results in significant functional and emotional sequel, although microsurgical repair techniques allowing more accurate axon alignment have been advanced. Differentiated nerve fascicle repair can maximize the functional recovery for the patient. Unfortunately, no method currently utilized can rapidly and accurately distinguish between the motor and sensory nerve fascicles during surgery. Surgeons today estimate the properties of both stumps of damaged PN fascicles through more-or-less experience, and perform inter-fascicular repair with limited insight as to outcome. The inability to find the specific molecule in motor or sensory nerve fascicles as a molecular marker in fresh and dated injured PN is partially responsible for failures in identifying nerve fascicles. Identifying specific marker in motor or sensory nerve fascicles will be intriguing and promising, which would allow surgeons to perform fascicular sutures elaborately and accurately in vivo, and result in the best recovery of the PN function. To this objective, we systematically reviewed the methods of identifying the motor or sensory fascicles and related technologies of today's Proteomics research which the predecessors had proposed, and appllied Comparative Proteomics to reveal proteins expression differences between the motor and sensory fascicles of PN. We clarified the volume changes of PN fascicles on different time points after the motor and sensory injured, revealed significant protein for PN regeneration, explored new clues to the identifying between motor and sensory fascicles and the molecular mechanism to damage repair of PN.
The principles, shortcomings, and progress of diverse methods of sensory and motor nerve fascicle identification, including nerve morphology, electric stimulation, spectroscopy, enzymatic staining (AchE and CA enzymatic staining methods), radiation biochemical methods and immunochemical methods, were systematically reviewed. Microsurgical techniques literature offered several papers which meticulously describe the nature of peripheral nerve and presumes that differentiating between the sensory and motor fascicles was difficult. The cross sections of the proximal and distal stumps of a nerve, which suffered from a substantial traumatic defect, fail to show mirror images and differ in their appearances. Nerve morphology alone could not far contribute to its identification. Various electric stimulation methods once tried to apply during the course of operation, which stimulated the dissected fascicles of the distal and proximal stumps. However, electric stimulation methods required local anesthesia and were imprecise or unpleasant to the patients. The majority of relevant papers mentioned enzymatic staining methods. However, nerve fascicles differentiation based on measurement of AchE or CA activity is limited since it requires lots of time on incubation, and cannot be used on dated PN injury that the enzyme activities step down in distal nerve stump for Wallerian degeneration. The radiochemical technical needed requirements and high costs, is limited in clinical applications. Methods such as intra-neural topography, electric stimulation, enzymatic staining and radiation biochemical methods used in attempting to solve this problem have either been imprecise, too time consuming, or unsuitable for intra-operative determination, are not suitable for clinical application. It is feasible in theory on identifying the motor or sensory fascicles of PN with immunochemical methods. But the marker proteins which the literature mentioned are challenged by many experts. How to choose a high-throughput screening around motor and sensory fascicles of PN, is a focus on identifying between motor and sensory fascicles of PN.
Through systematically reviewing the Proteomics and related technologies system of today's Proteomics, we believe that 2-D DIGE comparative proteomics approach and MALDI-TOF can be applied to choose a high-throughput screening around motor and sensory fascicles of PN. With these comparative proteomics approach, specific or high difference proteins can be found, and these proteins can give clues to the identifying between motor and sensory fascicles and the molecular mechanism to damage repair of PN.
To this objective, we made the following four experiments, and obtained corresponding results.
Experiment one, animal models:We optimized and established the Wistar rat PN injury animal models. Through deriving nerve sample from normal motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of PN,5mm far ends nerve sample from motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of 8 hours after PN Sunderland V injury,5mm far ends nerve sample from motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of 8 days after PN Sunderland V injury, we achieved the thoroughbred Wistar rats, the same injury model, the same injury time and the same sample preparation model.
Experiment two,2D-DIGE:Through optimizing the sample protein extraction method, protein samples purification, protein samples quantification, protein samples grouping and fluorescent labeling of extraction protein, we conducted fluorescence difference gel electrophoresis (DIGE), Typhoon 9400 laser scanner, DeCyder difference software analysis, DeCyder-BVA software matching proteins and got high differences proteins spots. The Results were that we established the fluorescent protein map of the motor branches of femoral nerve and saphenous nerve of PN, high differences proteins were high-throughput chosen between motor and sensory fascicles of PN. With the BVA software, gel analysis showed that an average of 1586 protein spots, protein spots matching rate of about 82% on nine gels. The pixel volume of each spot was calculated, normalized. Every gel was matched with the internal standard image in itself so as to gain the minimal gel-gel variance. To judge differences in protein expression, a cut-off value of a 1.5-fold increase or decrease was used. Among the protein spots detected, totally,160 protein spots were detected as changed upward or downward by>1.5 fold, P<0.05(using t test statistical method).
Experiment three, MALDI-TOF:Different protein spots were screened through artificial, then removed the less folds protein spots which might not be identified by mass spectrometry, finally,16 different protein spots were selected to identify. Throughreparing Coomassie staining gel, automatic spots picking, automatic restriction enzyme cutting, automatic spots targeting, then used MALDI-TOF Pro in reflector mode for peptide mass field fingerprinting (PMF map) to analyze and identify. The reliability of search results was evaluated by the expectations and coverage ratio. To search NCBI database using Pro Found software, resulted in 14 protein spots (ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1、DPYSL2、CaBP1、HSP70. Gng7、LDHB、Enolase2、Serpina 10. PDI A3) were identified exactly.
Experiment four:Realtime-PCR. We used Real-time method to validate the accuracy of Proteomics. Extracted total RNA from protein samples, RT-PCR, established PCR reaction system and conditions, and applied statistical analysis [two groups comparison with t test statistical method, multiple mean comparison with single factor variance One-Way ANOVA test and q test statistical method), through cross-groups comparing to one group as control, the other relative expression of the gene changes with multiple relationships, the data were normalized to detect mRNA changes of high difference proteins between the motor and sensory fascicles of PN injury at three time points. The results were that the trends of mRNA changes protein were close to the Proteomics results, thus validated the accuracy of Proteomics results.
Through bioinformatics query on high difference proteins, we got lots of the protein structures and functions of information about ApoE. NF-L、TEC、Serpina3n、Peroxiredoxin-2、 TPM1、DPYSL2、CaBP1、HSP70、Gng 7、LDHB、Enolase 2、Serpina 10、PDI A3, including: (1) There are indeed existing high difference proteins between the motor and sensory fascicles of normal PN. ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1 play important roles in the difference of the motor and sensory fascicles of normal PN. (2) High difference proteins TPM1、Serpina 10、DPYSL2、NF-L、CaBP1 are related with the sensory fascicles regeneration. (3) High difference proteins Serpina3n、Peroxiredoxin-2、HSP70、LDHB、Enolase 2、CaBP1、Serpina 10、Gng 7、PDI A3 are related with the motor fascicles regeneration. (4) ApoE in Y/G ratio is-1.94 times, good match, protein stability in all the gel, T-test statistic values are 0.00068, statistically significant;in 8HY/8HG ratio is-2.07 times, good match, protein stability in all the gel, T-test statistic values are 0.0053, statistically significant; in 8DY/8DG ratio is-2.20 times, good match, protein stability in all the gel, T-test statistic values are 0.0069, statistically significant. In the nerve sample from normal motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of PN,5mm far ends nerve sample from motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of 8 hours after PN Sunderland V injury,5mm far ends nerve sample from motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of 8 days after PN Sunderland V injury, ApoE in sensory fascicles are about 2 times upper and lower levels to ApoE in motor fascicles at three time points. ApoE might be served as the marker protein between sensory and motor fascicles, was worthy of further research.
The innovations of our research are:(1) It is the first time to apply Comparative Proteomics to screen the high difference proteins between the motor and sensory fascicles of PN. By far, there are no related researches on screening the high difference proteins between the motor and sensory fascicles of PN at different time points. (2) Our research break through the traditional study mode (protein changes in a single time point) which has ever been applied with. After PN injury, proteins amount changes with time (8h or 8d), subsequently, the application of the kind of protein should be changed when we wanted to use it to identify the motor or sensory fascicles of PN. It is a concept breakthrough to traditional concept of using single protein to identify the motor or sensory fascicles of PN at all time points. (3) Our research specifically divided the research mode of the protein changes after PN injury. We made a positive work on the study of proteins amount changes in sensory fascicles and proteins amount changes in motor fascicles at different time points after PN injury. So far, there is no report on the application of Comparative Proteomics to research the related protein amount changes of simple sensory or simple motor fascicles at different time point after PN injury. (4) ApoE might be used in identifying the motor or sensory fascicles of the fresh or dated PN injuries, and this experimental work provides the foundation for the clinical applications to identifying the motor or sensory fascicles of PN.
With high incidence of PN injuries and difficulty to cure, it is urgent for clinical work to study in-depth on high difference proteins between sensory and motor fascicles of PN, which can enrich the clinician's understanding of the PN injury and promote the progress on identifying the sensory or motor fascicles of PN. Therefore, our researches have important scientific significance and practical clinical value. And this research provided the follow-up object of study for the role of a single protein, directed the research area and accumulated raw data, carried out the preliminary experiments on identifying the sensory and motor fascicles of PN. At the same time, our research provided a new way of thinking to the repair of PN injury.
方法：通过对正常Wistar大鼠周围神经运动束和感觉束(股神经运动支和隐神经),在Sunderland V度损伤后8小时和8天分别在远侧断端切取5mm样本；6种样本共18组进行分离提取蛋白；蛋白质纯化及定量处理,应用差异凝胶电泳(DIGE)技术荧光标记各组蛋白质；凝胶图像扫描,用图像分析软件(DeCyder)全自动比较分析并识别各组间的差异表达蛋白质图谱；选择表达差异大于1.5倍的蛋白点；高差异蛋白点进行制备胶上自动切割、自动酶切、自动点靶,然后使用MALDI-TOF Pro质谱仪在反射场模式下进行肽质量指纹(PMF图谱)分析鉴定；应用Realtime-PCR技术分析比较蛋白质组学研究的结果。结果：应用2D-DIGE进行分离后,成功地获得了蛋白质组分辨率高、重复性好的荧光差异蛋白质图谱,用BVA软件分析显示9块凝胶平均分离1586个蛋白点。对于蛋白表达的统计学处理采用t检验。校准后选取在9块胶上均出现蛋白表达量上调或下调超过1.5倍、P<0.05的蛋白定义为高差异表达蛋白。本次发现实验组差异表达的蛋白共160个。最终选取16个高差异蛋白点分析鉴定,结果共有14个蛋白点被确切地鉴定。它们是：ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1、DPYSL2、CaBP1、HSP70、Gng 7、LDHB、Enolase2、Serpina 10、PDIA3。其中(1)周围神经感觉和运动束之间的高差异蛋白有：ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1。(2)与周围神经感觉束损伤后再生有关的高差异蛋白有：TPM1、DPYSL2、NF-L、Serpina 10、CaBPl。(3)与周围神经运动束损伤后再生有关的高差异蛋白有：Serpina3n、Peroxiredoxin-2、HSP70、LDHB、Enolase2、CaBP1、Serpina 10、Gng7、PDIA3。(4) ApoE在Y／G的比值是-1.94倍,匹配良好,蛋白稳定出现在所有胶中,T-test统计学数值是0.00068,具有统计学意义；8HY／8HG的比值是-2.07倍,匹配良好,蛋白稳定出现在所有胶中,T-test统计学数值是0.0053,具有统计学意义；8DY／8DG的比值是-2.20倍,匹配良好,蛋白稳定出现在所有胶中,T-test统计学数值是0.0069,具有统计学意义。ApoE在正常、Sunderland V度周围神经运动和感觉束(股神经运动支和隐神经)损伤后8小时远断端5mm和损伤后8天远断端5mm等三种时间点感觉束中含量是运动束的2倍左右,ApoE有望作为周围神经感觉和运动束的鉴别高差异标记蛋白。
结论：周围神经感觉束和运动束之间的比较蛋白质组学表达存在明显差异,这些差异蛋白质(ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1)为进一步阐明周围神经感觉束和运动束之间的生理功能差别以实现临床标记鉴别提供实验依据；筛选出对于周围神经感觉束和运动束在不同时间点的再生具有重要作用的蛋白(TPM1、Serpina 10、DPYSL2、NF-L、CaBP1、Serpina3n、Peroxiredoxin-2、HSP70、LDHB、Enolase2、Gng7、PDI A3),可利用这些蛋白在不同时间段的表达差异为临床周围神经再生干预提供新的研究手段。首次成功地把比较蛋白质组学应用于周围神经感觉束与运动束高差异标记物的筛选,现今国内外还没有应用比较蛋白质组学进行筛选周围神经感觉束与运动束不同时间点的差异蛋白的相关研究或报导；突破了传统的周围神经感觉束与运动束在单一时间点鉴别的观念；在探讨周围神经感觉束损伤后不同时间的蛋白质量的变化,和周围神经运动束损伤后不同时间的蛋白质量的变化上作了积极的工作。
Comparative proteomics reveals proteins expression differences between the motor and sensory fascicles of peripheral nerve
With high disability rate, the Peripheral Nerve (PN) injury has always troubled surgeons. PN injury results in significant functional and emotional sequel, although microsurgical repair techniques allowing more accurate axon alignment have been advanced. Differentiated nerve fascicle repair can maximize the functional recovery for the patient. Unfortunately, no method currently utilized can rapidly and accurately distinguish between the motor and sensory nerve fascicles during surgery. Surgeons today estimate the properties of both stumps of damaged PN fascicles through more-or-less experience, and perform inter-fascicular repair with limited insight as to outcome. The inability to find the specific molecule in motor or sensory nerve fascicles as a molecular marker in fresh and dated injured PN is partially responsible for failures in identifying nerve fascicles. Identifying specific marker in motor or sensory nerve fascicles will be intriguing and promising, which would allow surgeons to perform fascicular sutures elaborately and accurately in vivo, and result in the best recovery of the PN function. To this objective, we systematically reviewed the methods of identifying the motor or sensory fascicles and related technologies of today's Proteomics research which the predecessors had proposed, and appllied Comparative Proteomics to reveal proteins expression differences between the motor and sensory fascicles of PN. We clarified the volume changes of PN fascicles on different time points after the motor and sensory injured, revealed significant protein for PN regeneration, explored new clues to the identifying between motor and sensory fascicles and the molecular mechanism to damage repair of PN.
The principles, shortcomings, and progress of diverse methods of sensory and motor nerve fascicle identification, including nerve morphology, electric stimulation, spectroscopy, enzymatic staining (AchE and CA enzymatic staining methods), radiation biochemical methods and immunochemical methods, were systematically reviewed. Microsurgical techniques literature offered several papers which meticulously describe the nature of peripheral nerve and presumes that differentiating between the sensory and motor fascicles was difficult. The cross sections of the proximal and distal stumps of a nerve, which suffered from a substantial traumatic defect, fail to show mirror images and differ in their appearances. Nerve morphology alone could not far contribute to its identification. Various electric stimulation methods once tried to apply during the course of operation, which stimulated the dissected fascicles of the distal and proximal stumps. However, electric stimulation methods required local anesthesia and were imprecise or unpleasant to the patients. The majority of relevant papers mentioned enzymatic staining methods. However, nerve fascicles differentiation based on measurement of AchE or CA activity is limited since it requires lots of time on incubation, and cannot be used on dated PN injury that the enzyme activities step down in distal nerve stump for Wallerian degeneration. The radiochemical technical needed requirements and high costs, is limited in clinical applications. Methods such as intra-neural topography, electric stimulation, enzymatic staining and radiation biochemical methods used in attempting to solve this problem have either been imprecise, too time consuming, or unsuitable for intra-operative determination, are not suitable for clinical application. It is feasible in theory on identifying the motor or sensory fascicles of PN with immunochemical methods. But the marker proteins which the literature mentioned are challenged by many experts. How to choose a high-throughput screening around motor and sensory fascicles of PN, is a focus on identifying between motor and sensory fascicles of PN.
Through systematically reviewing the Proteomics and related technologies system of today's Proteomics, we believe that 2-D DIGE comparative proteomics approach and MALDI-TOF can be applied to choose a high-throughput screening around motor and sensory fascicles of PN. With these comparative proteomics approach, specific or high difference proteins can be found, and these proteins can give clues to the identifying between motor and sensory fascicles and the molecular mechanism to damage repair of PN.
To this objective, we made the following four experiments, and obtained corresponding results.
Experiment one, animal models:We optimized and established the Wistar rat PN injury animal models. Through deriving nerve sample from normal motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of PN,5mm far ends nerve sample from motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of 8 hours after PN Sunderland V injury,5mm far ends nerve sample from motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of 8 days after PN Sunderland V injury, we achieved the thoroughbred Wistar rats, the same injury model, the same injury time and the same sample preparation model.
Experiment two,2D-DIGE:Through optimizing the sample protein extraction method, protein samples purification, protein samples quantification, protein samples grouping and fluorescent labeling of extraction protein, we conducted fluorescence difference gel electrophoresis (DIGE), Typhoon 9400 laser scanner, DeCyder difference software analysis, DeCyder-BVA software matching proteins and got high differences proteins spots. The Results were that we established the fluorescent protein map of the motor branches of femoral nerve and saphenous nerve of PN, high differences proteins were high-throughput chosen between motor and sensory fascicles of PN. With the BVA software, gel analysis showed that an average of 1586 protein spots, protein spots matching rate of about 82% on nine gels. The pixel volume of each spot was calculated, normalized. Every gel was matched with the internal standard image in itself so as to gain the minimal gel-gel variance. To judge differences in protein expression, a cut-off value of a 1.5-fold increase or decrease was used. Among the protein spots detected, totally,160 protein spots were detected as changed upward or downward by>1.5 fold, P<0.05(using t test statistical method).
Experiment three, MALDI-TOF:Different protein spots were screened through artificial, then removed the less folds protein spots which might not be identified by mass spectrometry, finally,16 different protein spots were selected to identify. Throughreparing Coomassie staining gel, automatic spots picking, automatic restriction enzyme cutting, automatic spots targeting, then used MALDI-TOF Pro in reflector mode for peptide mass field fingerprinting (PMF map) to analyze and identify. The reliability of search results was evaluated by the expectations and coverage ratio. To search NCBI database using Pro Found software, resulted in 14 protein spots (ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1、DPYSL2、CaBP1、HSP70. Gng7、LDHB、Enolase2、Serpina 10. PDI A3) were identified exactly.
Experiment four:Realtime-PCR. We used Real-time method to validate the accuracy of Proteomics. Extracted total RNA from protein samples, RT-PCR, established PCR reaction system and conditions, and applied statistical analysis [two groups comparison with t test statistical method, multiple mean comparison with single factor variance One-Way ANOVA test and q test statistical method), through cross-groups comparing to one group as control, the other relative expression of the gene changes with multiple relationships, the data were normalized to detect mRNA changes of high difference proteins between the motor and sensory fascicles of PN injury at three time points. The results were that the trends of mRNA changes protein were close to the Proteomics results, thus validated the accuracy of Proteomics results.
Through bioinformatics query on high difference proteins, we got lots of the protein structures and functions of information about ApoE. NF-L、TEC、Serpina3n、Peroxiredoxin-2、 TPM1、DPYSL2、CaBP1、HSP70、Gng 7、LDHB、Enolase 2、Serpina 10、PDI A3, including: (1) There are indeed existing high difference proteins between the motor and sensory fascicles of normal PN. ApoE、NF-L、TEC、Serpina3n、Peroxiredoxin-2、TPM1 play important roles in the difference of the motor and sensory fascicles of normal PN. (2) High difference proteins TPM1、Serpina 10、DPYSL2、NF-L、CaBP1 are related with the sensory fascicles regeneration. (3) High difference proteins Serpina3n、Peroxiredoxin-2、HSP70、LDHB、Enolase 2、CaBP1、Serpina 10、Gng 7、PDI A3 are related with the motor fascicles regeneration. (4) ApoE in Y/G ratio is-1.94 times, good match, protein stability in all the gel, T-test statistic values are 0.00068, statistically significant;in 8HY/8HG ratio is-2.07 times, good match, protein stability in all the gel, T-test statistic values are 0.0053, statistically significant; in 8DY/8DG ratio is-2.20 times, good match, protein stability in all the gel, T-test statistic values are 0.0069, statistically significant. In the nerve sample from normal motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of PN,5mm far ends nerve sample from motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of 8 hours after PN Sunderland V injury,5mm far ends nerve sample from motor (motor branches of femoral nerve) and sensory (saphenous nerve) fascicles of 8 days after PN Sunderland V injury, ApoE in sensory fascicles are about 2 times upper and lower levels to ApoE in motor fascicles at three time points. ApoE might be served as the marker protein between sensory and motor fascicles, was worthy of further research.
The innovations of our research are:(1) It is the first time to apply Comparative Proteomics to screen the high difference proteins between the motor and sensory fascicles of PN. By far, there are no related researches on screening the high difference proteins between the motor and sensory fascicles of PN at different time points. (2) Our research break through the traditional study mode (protein changes in a single time point) which has ever been applied with. After PN injury, proteins amount changes with time (8h or 8d), subsequently, the application of the kind of protein should be changed when we wanted to use it to identify the motor or sensory fascicles of PN. It is a concept breakthrough to traditional concept of using single protein to identify the motor or sensory fascicles of PN at all time points. (3) Our research specifically divided the research mode of the protein changes after PN injury. We made a positive work on the study of proteins amount changes in sensory fascicles and proteins amount changes in motor fascicles at different time points after PN injury. So far, there is no report on the application of Comparative Proteomics to research the related protein amount changes of simple sensory or simple motor fascicles at different time point after PN injury. (4) ApoE might be used in identifying the motor or sensory fascicles of the fresh or dated PN injuries, and this experimental work provides the foundation for the clinical applications to identifying the motor or sensory fascicles of PN.
With high incidence of PN injuries and difficulty to cure, it is urgent for clinical work to study in-depth on high difference proteins between sensory and motor fascicles of PN, which can enrich the clinician's understanding of the PN injury and promote the progress on identifying the sensory or motor fascicles of PN. Therefore, our researches have important scientific significance and practical clinical value. And this research provided the follow-up object of study for the role of a single protein, directed the research area and accumulated raw data, carried out the preliminary experiments on identifying the sensory and motor fascicles of PN. At the same time, our research provided a new way of thinking to the repair of PN injury.
引文
[1]Frey M. Avulsion injuries to the brachial plexus and the value of motor reinnervation by ipsilateral nerve transfer [J]. J Hand Surg Br,2000,25(4):323-4.
[2]Nachemson AK. Axons regeneration and growth direction in square-shaped mesothelial chambers [J]. Scand J Plast Reconstr Surg Hand Surg,1988,22:199-206.
[3]Danielsen N, Dahlin LB, Lee YF, Lundborg G. Axonal growth in mesothelial chambers. The role of the distal nerve segment [J]. Scand J Plast Reconstr Surg,1983,17(2):119-25.
[4]Brushart TM, Seiler WA 4th. Selective reinnervation of distal motor stumps by peripheral motor axons [J]. Exp Neurol,1987,97(2):289-300.
[5]罗智捷,卢世璧.神经套接后混合神经中再生的运动和感觉纤维选择性重新支配靶器官[J].中华外科杂志,1996,34(1)：44-46.
[6]Seckel BR, Ryan SE, Gagne RG, et al. Target-specific nerve regeneration through a nerve guide in the rat [J]. Plast Reconstr Surg,1986,78(6):793-800.
[7]Brushart TM, Seiler WA 4th. Selective reinnervation of distal motor stumps by peripheral motor axons [J]. Exp Neurol,1987,97(2):289-300.
[8]Sunderland S. The intraneural topography of the radial, medial and ulnar nerve [J]. Brain, 1945,68(4):243-246.
[9]Sunderland S, Bradley KC. The cross-sectional area of peripheral nerve trunks devoted to nerve fibers [J]. Brain,1949,72(3):428-49.
[10]Jabaley ME, Wallace WH, Heckler FR. Internal topography of major nerves of the forearm and hand:A current view [J]. J Hand Surg Am,1980,5(1):1-18.
[11]Chow JA, Van Beek AL, Bilos ZJ, et al. Anatomical basis for repair of ulnar and median nerves in the distal part of the forearm by group fascicular suture and nerve-grafting [J]. J Bone Joint Surg Am,1986,68(2):273-80.
[12]钟世镇,刘牧之,周长满,等.正中神经的显微外科解剖学研究[J].解剖学报,1980,11：337-339.
[13]周长满.坐骨神经的显微外科解剖学研究[J].解剖学报,1984,15(2)：118-125.
[14]韩震,钟世镇,孙博,等.桡、尺、正中神经的自然分束在临床上的应用[J].中华外科杂志,1986,24：23.
[15]Watchmaker GP, Gumucio GA, Grandall RE, et al. Fascicular to photography of the median nerve:a computer based study to identify branching patterns [J]. J Hand Surg Am, 1991,16(1):53-59.
[16]Hakstian RW. Funicular orientation by direct stimulation, an aid to peripheral nerve repair [J]. J Bone Joint Surg Am,1968,50(6):1178-1186.
[17]Gaul JS Jr. Electrical fascicle identification as an adjunct to nerve repair [J]. J Hand Surg Am,1983,8(3):289-96.
[18]Gaul JS Jr. Electrical fascicle identification as an adjunct to nerve repair [J]. Hand Clin, 1986,2(4):709-22.
[19]朱家恺.周围神经束膜吻合术-探讨有关运动束与感觉束的区别方法[J].中国神经精神疾病杂志,1979,5(5)：229-231.
[20]Vandeput J, Tanner JC, Huypens L. Electro-physiological orientation of the cut ends in primary peripheral nerve repair [J]. Plast Reconstr Surg,1969,44(4):378-82.
[21]贾晓枫,张键,陈统一,等.神经束内微电极采集家兔周围神经电信号的实验研究[J].中华手外科杂志,2002,18(4)：245-247.
[22]Turkof E, Jurasch N, Knolle E, et al. Motor evoked potentials enable differentiation between motor and sensory branches of peripheral nerves in animal experiments [J]. J Reconstr Microsurg,2006,22(7):525-532.
[23]岳喜军,曹晓建,卜寿山,吕天润.近红外光谱和聚类分析法快速鉴别神经束性质的初步研究[J].南京医科大学学报(自然科学版),2006,26(5)：313-317.
[24]王虎,路来金,孔祥贵,刘东听,等.微区喇曼光谱法区分周围神经束性质[J].中国临床康复,2006,10(8)：104-106.
[25]王虎,路来金,刘东昕.周围神经束的快速鉴别[J].中国修复重建外科杂志,2008,22(1)：80-83.
[26]Koelle GB, Friedenwald JA. A histochemical method for localizing cholinesterase activity. Proc Soc Exp Biol Med,1949,70(4):617-22.
[27]Karnovsky MJ, Root L. A"direct-coloring" thiocholine method for cholinestcrase [J]. J histochem Cytochem,1964,12:219-21.
[28]Adams CW, Grant RT, Bayliss OB. Cholinesterases in peripheral nerves system I Mixed, motor and sensory trunks [J]. Brain Res,1967,5(3):366-76.
[29]Gruber H, Zenker W. Acetylcholinesterase:histochemical differentiation between motor and sensory nerve fibres [J]. Brain Reseach,1973,51:207-14.
[30]Gruber H. Identification of motor and sensory funiculi in cut nerves and their selective reunion [J]. Br J Plast Surg,1976,29:70-3.
[31]Freilinger G, Holle J, Sulxgruber SC. Distribution of motor and sensory fibers in the intercostal nerves. Significance in reconstructive surgery [J]. Plast Reconstr Surg,1978,62: 240-4.
[32]何蕴韶,钟世镇.人周围神经内乙酰胆碱酯酶活性与神经束性质的鉴别[J].解剖学报,1987,18(1)：7-11.
[33]Kanaya F. Mixed nerve suture facilitated by enzyme-staining techniques [J]. Tech Hand Up Extrem Surg,2002,6(3):140-4.
[34]Kanaya F, Ogden L, Breidenbach WC, et al. Sensory and motor fiber differentiation with Karnovsky staining [J]. J Hand Surg Am,1991,16(5):851-8.
[35]Deutinger M, Girsch W, Burggassor G, et al.Peripheral nerve repair in the hand with and without motor sensory differentiation [J]. Hand Surg Am,1993,18(3):426-32.
[36]Girsch W, Deutinger M, Bayer GS, et al.Sensorimotor differentiated reconstruction of peripheral nerves--a methods of intraoperative identification of motor fascicles [J]. Handchir Mikrochir Plast Chir,1996,28(4):181-6.
[37]Hansson HP. Histochemical demonstration of carbonic anhydrase activity [J]. Histochemie, 1967,11:112-28.
[38]Riley DA, Lang DH. Carbonic anhydrase activity of human peripheral nerves:a possible histochemical aid to nerve repair [J]. J Hand Surg,1984,9A(1):112-20.
[39]Riley DA, James RS, Sanger JR, et al. Identifying motor and sensory myelinated axons in rabbit peripheral nerves by histochemical staining for carbonic anhydrase and cholinesterase activities [J]. Brain Res.1988,453(1-2):79-88.
[40]周长满,郭海梅.鉴别神经功能束的碳酸酐酶显示法[J].临床应用解剖学杂志,1986,3(3)：148-150.
[41]Carson KA, Tezis JK. Carbonic anhyrace histochemistry. A potential diagnostic method for peripheral nerve repair [J]. Clin Plast Surg,1985,12(2):227-32.
[42]Hattori Y, Doi K, Fukushima S, Kaneko K. The diagnostic value of intraoperative measurement of choline acetyltransferase activity during brachial plexus surgery [J]. J Hand Surg Br,2000,25(5):509-11.
[43]Sanger JR, Riley DA, Matloub HS, et al. Effects of axotomy on the cholinesterase and carbonic anhydrase activities of axons in the proximal and distal stumps of rabbit sciatic nerves:a temporal study [J]. Plast Reconstr Surg,1991,87(4):726-38.
[44]Liu XL, Zhu JK. The histochemical study of rat sciatic nerve cholinesterase in degeneration and regeneration [J]. J Reconstr Microsurg,1990,6(1):43-7.
[45]Engel J, Ganel A, Melamed R, et al. Choline acetyltransferase for differentiation between human motor and sensory nerve fibers [J]. Ann Plast Surg.1980;4(5):376-80.
[46]Ganel A, Farine I, Aharonson Z, et al. Intraoperative nerve fascicle identification using choline acetyltransferase:a preliminary report [J].Clin Orthop Relat Res.1982;(165): 228-32.
[47]Keller A, Margolis FL. Isolation and eliaracterization of rat olfactory marker proteins [J].J Biol Chem,1976,251(20):6232-7.
[48]Norris BJ, Calabrese RL. Identification of motor neutrons that Contain a FMRF amidelike peptide and the effects of FMRFamide on longitudinal muscle in the medicinal leech, Hirudo medicinalis [J]. J comp Neurol,1987,266 (1):95-111.
[49]Borges LF, Iversen SD. Topography of choline acetyltransferase immunoreactive neurons and fibers in the rat spinal cord [J]. Brain Res,1986,362(1):140-8.
[50]Juurlink BH, Munoz DG, Devon RM. Calcitonin gene-related peptide identifies spinal motoneurons in vitro [J]. J Neurosci Res,1990,26(2):238-41.
[51]Hietanen M, Pelto-Huikko M, Rechardt L. Immunocytochemical study of the relations of acetylcholineterase, enkephalin-, substance P-, choline acetyltransferase-and calcitonin gene-related peptide-immunoreactive structures in the ventral horn of rat spinal cord [J].Histochemistry,1990,993(5):473-7.
[52]Urakami H, Chiu AY. A monoclonal antibody that recognizes somatic motor neurons in the mature rat nervous system [J]. J Neurosci,1990,10(2):620-30.
[53]Erkman L, Mattenberger L, Kato AC. A monoclonal antibody distinguishes anterior horn cells of human embryonic spinal cord during a transient period of development [J]. Brain Res Dev Brain Res,1992,66(1):109-17.
[54]Sieber-Blum M. SSEA-1 is a specific marker for the spinal sensory neuron lineage in the quail embryo and in neural crest cell cultures [J]. Dev Biol,1989,134(2):362-75.
[55]Boland LM, Dingledine R. Expression of sensory neuron antigens by a dorsal root ganglion cell line, F-11 [J]. Brain Res Dev Brain Res,1990,51(2):259-66.
[56]严志强,王友华,张沛云,顾晓松.快速免疫组化法区分人周围神经束性质[J].中华显微外科杂志,1996,19(1)：3-5.
[57]XIE jianxun, PU xiaoping, Bao jinfeng, et al. Purification and Identification of a 35 kD Specific Protein (SSP235) of Rat Spinal Sensory Ganglia [J]. Chinese Journal of Biochemistry and Molecular Biology,2001,17(3):306-310.
[58]于昌玉,张咸中,胡玉弘,等.酶联免疫吸附试验技术用于周围神经束定性染色的实验研 究[J].中华手外科杂志,1994,10(3)：176-178.
[59]刘璠,王友华,严志强,等.分子免疫染色法鉴别人体周围神经感觉纤维的实验研究及临床应用[J].中华手外科杂志,1996；12(1)：6-7.
[60]蒲小平,汪家政,顾晓松,范明.兔感觉神经特异蛋白的纯化及稳定性观察[J].生物化学与生物物理进展,1997,24(5)：465-466.
[6l]蒲小平,汪家政,范明,李长龄.脊神经节感觉神经特异蛋白的分离纯化和鉴定[J].生物物理学报,1999,15(2)：315-319.
[62]Matsuda R, Kaneko N, Kikuchi M, et al. Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room [J]. Resuscitation,2003,57(2): 171-7.
[63]Spreca A, Rambotti MG, Giambanco I, et al. Immunocytochemical localization of annexin V (CaBP33), a Ca(2+)-dependent phospholipid-and membrane-binding protein, in the rat nervous system and skeletal muscles and in the porcine heart [J]. J Cell Physiol,1992, 152(3):587-98.
[64]Gotow T, Sakata M, Funakosh T, Uchiyama Y. Preferential localization of annexin V to the axon terminal [J]. Neuroscience,1996,75(2):507-521.
[65]王虎,刘东昕,杜世新.快速组化法快速鉴别周围神经束性质[J].中国现代医生,2008,46(16)：83-85.
[66]Godfrey EW, Nitkin RM, Wallace BG, et al. Components of Torpedo electric organ and muscle that cause aggregation of acetylcholine receptors on cultured muscle cells [J]. J Cell Biol,1984,99(2):615-627.
[67]Burgess RW, Nguyen QT, Son YJ, et al. Alternatively spliced isoforms of nerve-and muscle-derived agrin:their roles at the neuromuscular junction [J]. Neuron,1999,23 (1):33-44.
[68]Ma J, Lugo B, Shah S, et al. Synaptic localization and axonal targeting of agrin secreted by ventral spinal cord neurons in culture [J]. J Neurobiol,2000,15,43(4):338-51.
[69]曾嵘,夏其昌.蛋白质组学研究进展与趋势[J].中国科学院院刊,2002,17(3)：166-169.
[70]Cheung VG, Nowak N, Jang W, et al. Integration of cytogenetic landmarks into the draft sequence of the human genome [J]. Nature,2001,15,409(6822):953-8.
[71]Koonin EV, Wolf YI, Karev GP. The structure of the protein universe and genome evolution [J]. Nature,2002,420(6912):218-23.
[72]Wilkins MR, Sanchez JC, Gooley AA, et al. Progress with proteome projects:why all proteins expressed by a genome should be identified and how to do it [J]. Biotechnol Genet Eng Rev.1996,13:19-50.
[73]de Hoog CL, Mann M. Proteomics [J]. Annu Rev Genomics Hum Genet,2004,5:267-293.
[74]Rappsilber J, Mann M. What does it mean to identify a protein in proteomics [J]. Trends Biochem Sci,2002,27(2):74-78.
[75]Humphery-Smith I, Cordwell SJ, Blackstock WP. Proteome research:complementarity and limitations with respect to the RNA and DNA worlds [J]. Electrophoresis,1997,18(8): 1217-42.
[76]Anderson NL, Anderson NG. Proteome and proteomics:a new technologies, new concepts and new words [J]. Electrophoresis,1998,19(11):1853-61.
[77]Fang X, Balgley BM, Lee CS. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery [J]. Electrophoresis,2009,30(23): 3998-4007.
[78]Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues.A novel approach to testing for induced point mutations in mammals [J]. Humangenetik,1975,26(3):231-43.
[79]O'Farrell PH. High resolution two-dimensional electrophoresis of proteins [J]. J Biol Chem,1975,250 (10):4007-21.
[80]Nilsson CL, Larsson T, Gustafsson E, et al. Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry [J]. Anal Chem,2000,72(9):2148-53.
[81]Fey SJ, Larsen PM.2D or not 2D. Two-dimensional gel electrophoresis [J]. Curr Opin Chem Biol.2001; 5(1):26-33.
[82]Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis:a single gel method for detecting changes in protein extracts [J]. Electrophoresis,1997,18(11):2071-7.
[83]Alban A, David SO, Bjorkesten L, et al. A novel experimental design for comparative two-dimensional gel analysis:two-dimensional difference gel electrophoresis incorporating a pooled internal standard [J]. Proteomics,2003,3(1):36-44.
[84]Van den Bergh G, Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics [J]. Curr Opin Biotechnol,2004,15(1):38-43.
[85]Zhou G, Li H, DeCamp D, et al.2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers [J]. Mol Cell Proteomics,2002, 1(2):117-24.
[86]Yan JX, Devenish AT, Wait R, et al. Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli [J]. Proteomics,2002,2(12):1682-98.
[87]Friedman DB, Hill S, Keller JW, et al. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry [J]. Proteomics, 2004,4(3):793-811.
[88]Costello CE. Bioanalytic applications of mass spectrometry [J]. Curr Opin Biotechnol, 1999,10(1):22-8.
[89]McLafferty FW, Fridriksson EK, Horn DM, et al. Techview:biochemistry. Biomolecule mass spectrometry [J]. Science,1999,284(5418):1289-90.
[90]Han X, Jin M, Breuker K, McLafferty FW. Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons [J]. Science,2006,314(5796):109-112.
[91]Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons [J]. Anal Chem,1988,60(20):2299-2301.
[92]Fenn JB, Mann M, Meng CK, et al. Electrospray ionization for mass spectrometry of large biomolecules [J]. Science,1989,246(4926):64-71.
[93]Pappin DJ, Hojrup P, Bleasby AJ. Rapid identification of proteins by peptide-mass fingerprinting [J]. Curr Biol,1993,3(6):327-332.
[94]Mann M, Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags [J]. Anal Chem,1994,66(24):4390-99.
[95]应万涛,钱小红.生物质谱技术应用及进展[J].军事医学科学院院刊,2000,6(24)：146.
[96]Biemann K. Sequencing of peptides by tandem mass spectrometry and high-energy collision-induced dissociation [J]. Methods Enzymol,1990,193:455-79.
[97]Yates JR 3rd, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database [J]. Anal Chem,1995,67(8):1426-1436.
[98]Hirosawa M, Hoshida M, Ishikawa M, Toya T. MASCOT:multiple alignment system for protein sequences based on three-way dynamic programming [J]. Comput Appl Biosci,1993,9(2):161-167.
[99]Palagi PM, Hernandez P, Walther D, Appel RD. Proteome informatics I:bioinformatics tools for processing experimental data [J]. Proteomics,2006,6(20):5435-44.
[100]Vihinen M. Bioinformatics in proteomics [J]. Biomol Eng,2001,18(2):241-8.
[101]Brown LM, Helmke SM, Hunsucker SW, et al. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue [J]. Mol Carcinog,2006,45(8):613-26.
[102]Gade D, Thiermann J, Markowsky D, Rabus R. Evaluation of two-dimensional difference gel electrophoresis for protein profiling. Soluble proteins of the marine bacterium Pirellula sp. strain 1 [J]. J Mol Microbiol Biotechnol,2003,5(4):240-51.
[103]Hu Y, Wang G, Chen GY, et al. Proteome analysis of Saccharomyces cerevisiae under metal stress by two-dimensional differential gel electrophoresis [J]. Electrophoresis,2003, 24(9):1458-70.
[104]Maeda K, Finnie C, Svensson B:Identification of thioredoxin h-reducible disulphides in proteomes by differential labelling of cysteines:insight into recognition and regulation of proteins in barley seeds by thioredoxin h [J]. Proteomics,2005,5(6):1634-44.
[105]Hoffert JD, van Balkom BW, Chou CL, Knepper MA. Application of difference gel electrophoresis to the identification of inner medullary collecting duct proteins [J]. Am J Physiol Renal Physiol,2004,286(1):F170-9.
[106]Heinemann FS, Korza G, Ozols J. A plasminogen-like protein selectively degrades stearoyl-CoA desaturase in liver microsomes [J]. J Biol Chem,2003,278(44):42966-75.
[107]Anazawa Y, Nakagawa H, Furihara M, et al. PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein ATF-Ibeta/SET [J]. Cancer Res,2005,65(11):4578-86.
[108]Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry [J]. J Proteome Res,2005,4(5):1742-51.
[109]Guest PC, Knowles MR, Molon-Noblot S, et al. Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling [J]. Brain Res,2004,1002(1-2): 1-10.
[110]Cristea IM, Gaskell SJ, Whetton AD. Proteomics techniques and their application to hematology [J]. Blood,2004,103(10):3624-34.
[111]. Somiari RI, Sullivan A, Russell S, et al. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast [J]. Proteomics,2003,3(10):1863-73.
[112]Qualtieri A, Le Pera M, et al. Two-dimensional gel electrophoresis of peripheral nerve proteins:Optimized sample preparation [J]. J Neurosci Methods,2007,159(1):125-33.
[113]Jimenez CR, Stam FJ, Li KW, et al. Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regeneration [J]. Mol Cell Proteomics,2005,4(2): 120-32.
[114]Huang HL, Cendan CM, Roza C, et al. Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves [J]. Mol Pain,2008,12,4:33.
[115]Cho WC. Proteomics technologies and challenges [J]. Genomics Proteomics Bioinformatics,2007,5(2):77-85.
[116]Sunderland S. Nerves and nerve injurues.2nd ed, Edinburgh:Churchill Livingstone,1978.
[117]Becker K, Pan D, Whitely CB. Real-time quantitative polymerase chain reaction to assessgene transfer [J]. Human Gene Ther,1999,10(15):2559-2566.
[118]Shore VG, Shore B. Heterogeneity of human plasma very low density lipoproteins. Separation of species differingin protein components [J]. Bioehemistry,1973,12(3): p.502-7.
[119]Mahley RW. Apolipoprotein E:cholesterol transport protein with expanding role in cell biology [J]. Science.1988,240(4852):622-30.
[120]Ignatius MJ, Shooter EM, Pitas RE, Mahley RW. Lipoprotein uptake by neuronal growth cones in vitro [J]. Science,1987,236(4804):959-62.
[121]Paik YK, Chang DJ, Reardon CA, et al. Nucleotide sequence and structure of the human apolipoprotein E gene [J]. Proc Natl Acad Sci U S A,1985,82(10):3445-9.
[122]Breslow JL. Transgenic mouse models of lipoprotein metabolism and atherosclerosis [J]. Proc Natl Acad Sci U S A,1993,90(18):8314-8.
[123]Wetterau JR, Aggerbeck LP, Rall SC Jr, Weisgraber KH. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains [J]. J Biol Chem,1988, 263(13):6240-8.
[124]Masliah E, Mallory M, Veinbergs I, et al. Alterations in apolipoprotein E expression during aging and neurodegeneration [J]. Prog Neurobiol,1996,50(5-6):493-503.
[125]Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease [J]. Lancet,1993,342(8873):697-9.
[126]Weisgraber KH, Roses AD, Strittmatter WJ. The role of apolipoprotein E in the nervous system [J]. Curr Opin Lipidol,1994,5(2):110-6.
[127]Mahley RW, Rall SC Jr. Apolipoprotein E:far more than a lipid transport protein [J]. Annu Rev Genomics Hum Genet,2000; 1:507-37.
[128]Han SH, Einstein G, Weisgraber KH, et al. Apolipoprotein E is localized to the cytoplasm of human cortical neurons:a light and electron microscopic study [J]. J Neuropathol Exp Neurol,1994,53(5):535-44.
[129]Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve [J]. J Clin Invest,1989,83(3):1015-31.
[130]Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease [J]. Trends Neurosci,1994,17(12):525-30.
[131]Sparks DL, Liu H, Gross DR, Scheff SW. Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol [J]. Neurosci Lett,1995,187(2):142-4.
[132]Avila EM,Holdsworth QSasaki N,et al. Apoprotein E suppresses phytohemagglutiriin-activated phospholipid turnover in peripheral blood mononuclear cells [J]. J Biol Chem,1982,257(10):5900-9.
[133]Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice [J]. Circulation,2001, 104(2):197-202.
[134]Yu S, Duan RS, Chen Z, et al. Increased susceptibility to experimental autoimmune neuritis after upregulation of the autoreactive T cell response to peripheral myelin antigen in apolipoprotein E-deficient mice [J]. J Neuropathol Exp Neurol,2004,63(2):120-8.
[135]Gaillard O, Gervais A, Meillet D, et al. Apolipoprotein E and multiple sclerosis:a biochemical and genetic investigation [J]. J Neurol Sci,1998,158(2):180-6.
[136]Larner AJ, Johnson AR, Keynes RJ. Regenertion in the vertebrate central nervous system: phylogeny, ontnoeny, and mechanisms [J]. Biol Rev,1995,70(4):597-619.
[137]Schwab ME, Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord [J]. Physiol Rev,1996,76(2):319-370.
[138]Mullins FH, Hargreaves AJ, Li JY, et al. Tyrosination state of alpha-tubulin in regenerating peripheral nerve [J]. J Neurochem,1994,62(1):227-34.
[139]Scott D, Smith KE, O'Bhen BJ, et al. Characterization of mammalian neurofilament triplet proteins [J]. J Biol Chem,1985,260(19):10736-10747.
[140]Fliegner KH, Liem RK. Cellular and molecular biology of neuronal intermediate filaments [J]. Int Rev Cytol,1991,131:109-67.
[141]Hisanaga S, Ikai A, Hirokawa N. Molecular architecture of the neurofilament. I. Subunit arrangement of neurofilament L protein in the intermediate-sized filament [J]. J Mol Biol,1990,211(4):857-69.
[142]Hisanaga S, Hirokawa N. Molecular architecture of the neurofilament. Ⅱ. Reassembly process of neurofilament L protein in vitro [J]. J Mol Biol,1990,211(4):871-82.
[143]Hirokawa N. Cross-linker system between neurofilaments, microtubules, and membranous organelles in frog axons revealed by the quick-freeze, deep-etching method [J]. J Cell Biol,1982,94(1):129-42.
[144]Elder GA, Friedrich VL Jr, Bosco P, et al. Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content [J]. J Cell Biol,1998,141(3):727-39.
[145]Zhu Q, Couillard-Despres S, Julien JP. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments [J]. Exp Neurol,1997,148(1):299-316.
[146]Yabe J T, Wang F S, Chylinski T, et al. Selective accumulation of the high molecular weight neurofilament subunit within the distal region of growing axonal neuritis [J]. Cell Motil Cytoskeleton,2001,50(1):1-12.
[147]Uchida A, Brown A. Arrival, reversal, and departure of neurofilament at the tip s of growing axons [J]. Mol Biol Cell,2004,15(9):4215-4225.
[148]Uchida K, Baba H, Maczawa Y, et al. Progressive changes in neurofilament p roteins and growth associated p rotein-4 3 immunoreactivities at the site of cervical spinal cord compression in spinal hyerostotic mice [J]. Spine,2002,27(5):480-487.
[149]Miller FD, Tetzlaff N, Bisby MA, et al. Rapid induction of major embryonica-tubulin during nerve regeneration in adult rats [J]. J Neurosci,1989,9(4):1452-63.
[150]Gan SD, Fan M, He GP. The role of microtubule in axoplasmia transport in vivo [J].Brain Res,1986,369 (122):75-82.
[151]Mitchison T, Kirschner M. Cytoskeletal dynamics and nerve growth [J]. Neuron,1988,1 (9):761-72.
[152]Oblinger MM, Argasinski A, Wong J, et al. The gene expression in rat sensory neurons during development and regeneration [J]. J Neurosci,1991,11(8):2453-59.
[153]米瑞发,周长满,范明.大鼠坐骨神经损伤后背根节感觉神经元神经丝蛋白基因表达的变化[J].解剖学报,2001,32(4)：324-328.
[154]Miller CC, Ackerley S, Brownlees J, et al. Axonal transport of neurofilaments in normal and disease states[J].Cell Mol Life Sci,2002;59(2):323-330.
[155]Bajo M, Yoo BC, Cairns N, et al. Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease [J]. Amino Acids,2001, 21(3):293-301.
[156]Nakamura Y, Hasimoto R, Kashiwagi Y, et al. Abnormal distribution of neurofilament L in neurons with Alzheimer's disease [J]. Neurosci Lett,1997,225(3):201-4.
[157]Lee MK, Cleveland DW. Neuronal intermediate filaments [J]. Annu Rev Neurosci,1996, 19:187-17.
[158]Kane LP,Watkins SC.Dynamic regulation of Tec kinase localization in membrane-proximal vesicles of a T cell clone revealed by total internal reflection fluorescence and confocal microscopy [J]. J Biol Chem,2005,280(23):21949-54.
[159]Takesono A, Finkelstein LD, Schwartzberg PL. Beyond calcium:new signaling pathways for Tec family kinases [J]. J Cell Sci,2002,115(Pt 15):3039-48.
[160]Mano H, Ishikawa F, Nishida J, et al. A novel protein-tyro sine kinase, tec, is preferentially expressed in liver [J]. Oncogene,1990,5(12):1781-6.
[161]Xu W, Wang S, Wang G, et al. Identification and characterization of differentially expressed genes in the early response phase during liver regeneration [J]. Biochem Biophys Res Commun,2000,278(2):318-25.
[162]Fruman DA, Snapper SB, Yballe CM, et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha [J]. Science,1999, 283(5400):393-7.
[163]Suzuki H, Terauchi Y, Fujiwara M, et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase [J]. Science,1999, 283(5400):390-2.
[164]Bolen JB. Nonreceptor tyrosine protein kinases [J]. Oncogene,1993,8(8):2025-31.
[165]Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL. Tec family kinases in T lymphocyte development and function [J]. Annu Rev Immunol,2005;23:549-600.
[166]Finkelstein LD, Shimizu Y, Schwartzberg PL, et al. Tec kinases regulate TCR-mediated recruitment of signaling molecules and integrin-dependent cell adhesion [J]. J Immunol,2005,175(9):5923-30.
[167]Finkelstein LD, Schwartzberg PL. Tec kinases:shaping T-cell activation through actin [J]. Trends in Cell Biology,2004,14(8):443-451.
[168]Qin Y, Kung HJ. Signaling network of the Btk family kinases [J]. Oncogene, 2000,19(49):5651-5661.
[169]Hastings GA, Colemna TA, Haudenschild CC, et al. Neuroseprin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons [J]. J Biol Chem,1997;272(52):33062-7.
[170]Sipione S, Simmen KC, Lord SJ, et al. Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cells [J]. J Immunol,2006,177(8):5051-5058.
[171]Docagne F, Nicole O, Marti HH, et al. Transforming growth factor-betal as a regulator of the serpins/t-PA axis in cerebral ischemia [J]. FASEB J,1999,13(11):1315-24.
[172]Yepes M, Sandkvist M, Coleman TA, et al. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent [J]. J Clin Invest,2002,109(12):1571-1578.
[173]Simonin Y, Charron Y, Sonderegger P, et al. An inhibitor of serine proteases, neuroserpin, acts as a neuroprotective agent in a mouse model of neurodegenerative disease [J]. Journal of Neuroseienee,2006,26(41):10614-10619.
[174]Groot DM, Martens GJ. Expression of neuroserpin is linked to neuroendoerine cell activation [J]. Endocrinology,2005,146(9):3791-3799.
[175]Galliciotti G, Sonderegger P. Neuroserpin [J]. Frontiers in Bioscience,2006,11:33-45.
[176]Wang X, Phelan SA, Forsman-Semb K, et al. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress [J]. J Biol Chem,2003,278(27):25179-90.
[177]Rabilloud T, Heller M, Gasnier F, et al. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site [J]. J Biol Chem,2002,277(22):19396-401.
[178]Crowley-Weber CL, Payne CM, G leason-Guzman M, et al. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate [J]. Carcinogenesis,2002,23(12):2063-80.
[179]Somiari R1, Sullivan A, Russell S, et al. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast [J]. Proteomics,2003,3(10):1863-73.
[180]Park SY, Yu X, Ip C, et al. Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation [J]. Cancer Res,2007,67(19):9294-9303.
[181]Donnelly S, Stack CM, O'Neill SM, et al. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages [J]. FASEB J,2008,22(11):4022-32.
[182]Kang SW, Chang TS, Lee TH, et al. Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-alpha [J]. J Biol Chem,2004,279(4):2535-43.
[183]Makino Y, Okamoto K, Yoshikawa N, et al. Thioredoxin:a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system [J]. J Clin Invest,1996,98(11):2469-77.
[184]Bharadwa JS, prasad GL. Tropomyosin-1, a novel suppressor of cellular transformation is down regulated by promoter methylation in cancer cells [J]. Cancer Lett,2002, 183(2):205-213.
[185]Perry SV. Vertebrate tropomyosin:distribution, properties and function [J]. J Muscle Res Cell Motil,2001,22(1):5-49.
[186]Pittenger MF, Kazzaz JA, Helfman DM. Functional properties of non-muscle tropomyosin isoforms [J]. Curr Opin Cell Biol,1994,6(1):96-104.
[187]Mahadev K, Raval G, Bharadwaj S, et al. Suppression of the transformed phenotype of breast cancer by tropomyosin [J]. Exp Cell Res,2002,279(l):40-51.
[188]Raval GN, Bharadwaj S, Levine EA, et al. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors [J].Oncogene, 2003,22(40):6194-6203.
[189]Franzen B, Linder S, Uryu K, et al. Expression of tropomyosin isoforms in benign and malignant human breast lesions [J]. Br J Cancer,1996,73(7):909-913.
[190]Nakata K, Ujike H, Sakai A, et al. The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia [J]. Biol Psychiatry,2003,53(7):571-6.
[191]Zhao X, Tang R, Xiao Z, et al. An investigation of the dihydropyrimidinase-like 2(DPYSLZ) gene in schizophrenia:genetic association study and expression analysis [J]. Int J Neuropsychopharmacol,2006,9(6):705-712.
[192]Nishimura T, Fukata Y Kato K, et al. CRMP-2 regulates polarized Numbmediated endocytosis for axon growth [J]. Nat Cell Biol,2003,5(9):819-26.
[193]Weitzdoerfer R, Fountoulakis M, Lubec G. Aberrant expression of dihydropyrimidinase related proteins-2,-3 and-4 in fetal Down syndrome brain [J]. J Neural Transm Suppl,2001,(61):95-107.
[194]Vincent P, Collette Y, Marignier R, et al. A role for the neuronal protein collapsing response. mediator protein 2 in T lymphocyte polarization and migration [J]. J Immunol,2005,175(11):7650-60.
[195]Chung MA, Lee JE, Lee JY, et al. Alteration of collapsing response mediator protein-2 expression in focal ischemic rat brain [J]. Neuroreport,2005,16(15):1647-53.
[196]Peter F, Nguyen Van P, Soling HD. Different sorting of Lys-Asp-Glu-Leu proteins in rat liver [J]. J Biol Chem,1992,267(15):10631-7.
[197]Ellgaard L, Ruddock LW. The human protein disulphide isomerase family:substrate interactions and functional properties [J]. EMBO Rep,2005,6(1):28-32.
[198]Seidenbecher CI, Landwehr M, Smalla KH, et al. Caldendrin but not calmodulin binds to light chain 3 of MAP1A/B:an association with the microtubule cytoskeleton highlighting exclusive binding partners for neuronal Ca(2+)-sensor proteins [J]. J Mol Biol, 2004,336(4):957-70.
[199]Wingard JN, Chan J, Bosanac I, et al. Structural analysis of Mg2+and Ca2+binding to CaBPl, a neuron-specific regulator of calcium channels [J]. J Biol Chem,2005, 280(45):37461-70.
[200]Haynes LP, Tepikin AV, Burgoyne RD. Calcium-binding protein 1 is an inhibitor of agonist-evoked, inositol 1,4,5-trisphosphate-mediated calcium signaling [J]. J Biol Chem,2004,279(1):547-55.
[201]German DC, Manaye KF, Sonsalla PK, Brooks BA. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism:sparing of calbindin-D28k-containing cells [J]. Ann N Y Acad Sci,1992,648:42-62.
[202]胡轶虹,常明,张瑜,等.PSI诱导的PC12细胞胞浆内胞核旁嗜酸性包涵体的形成及演变过程[J].中风与神经疾病杂志,2007,24：20-22.
[203]Nishi S, Taki W, Uemura Y, et al. Ischemic tolerance due to the induction of HSP70 in a rat ischemic recirculation model [J]. Brain Res,1993,615(2):281-8.
[204]Pasqualini R, Bourdoulous S, Koivunen E, et al. A polymeric form of fibronectin has antimetastatic effects against multiple tumor types [J]. Nat Med,1996,2(11):1197-203.
[205]Suzuki T, Usuda N, Murata S, et al. Presence of molecular chaperones, heat shock cognate (Hsc) 70 and heat shock proteins (Hsp) 40, in the postsynaptic structures of rat brain [J]. Brain Res,1999,16;816(1):99-110.
[206]Kinouchi H, Sharp FR, Koistinaho J, et al. Induction of heat shock hsp70 mRNA and HSP70 KDa protein in neurons in the'penumbra' following focal cerebral ischemia in the rat [J]. Brain Res,1993,619 (1-2):334-338.
[207]Kato H, Kogure K. Boichemical and molecular characteristic of the brain with developing cerebral infarction [J]. Cell Mol Neurobiol,1999,19 (1):93-96.
[208]Tobaber S, Thakur P, Fernandez-Chacon K, et al. A trimeric protein complex functions as a synaptic chaperone machine [J].Neuron,2001,31(6):987-999.
[209]Isomoto H, Oka M, Yano Y, et al. Expression of heat shock protein (Hsp)70 and Hsp 40 in gastric cancer [J].Cancer Lett,2003,198(2):219-228.
[210]Aghdassi A, Phillips P, Dudeja V, et al. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma [J]. Cancer Res,2007,67(2):616-625.
[211]Xiong Ren Ping, Liu Ping,Zhou Yuan Guo, et al. Extraction of trace total RNA and protein from small quantity cultured cells [J]. Chin J Biochem Mol Biol,2003, 19(2):256-260.
[212]Schwacha MG, Somers SD. Thermal injury induces macrophage hyperactivity through pertussis toxin-sensitive and-insensitive pathways [J]. Shock,1998,9(4):249-55
[213]Grant KR, Harnett W, Milligan G, Harnett MM. Differential G-protein expression during B-and T-cell development [J]. Immunology,1997,90(4):564-71.
[214]Dairaghi DJ, Soo KS, Oldham ER, et al. RANTES-induced T cell activation correlates with CD3 expression [J]. J Immunol,1998,160(1):426-33.
[215]Griguer CE, Oliva CR, Gillespie GY. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines [J]. J Neurooncol,2005,74(2):123-33.
[216]Liu ZJ, Peng WC, Yang X, et al. Relative mRNA expression of the lactate dehydrogenase A and B subunits as determined by simultaneous amplification and single strand conformation polymorphism.Relation with subunit enzyme activity [J]. J Chromatogr B Analyt Technol Biomed Life Sci,2003,793(2):405-412.
[217]Sudo K, Maekawa M, Houki N, et al. A novel in-frame deletion mutation in a case of lactate dehydrogenase (LD)H subunit deficiency showing an atypical LD isoenzyme pattern in serum and erythrocytes [J].Clin Biochem,1999,32(2):137-141.
[218]Chen Y, Zhang H, Xu A, et al. Elevation of serum 1-lactate dehydrogenase B correlated with the clinical stage of lung cancer [J].Lung Cancer,2006,54(l):95-102.
[219]Santonocito C, Concolino P, Lavieri MM, et al. Comparison between three molecular methods for detection of blood melanoma tyrosinase mRNA. Correlation with melanoma stages and S100B, LDH, NSE biochemical markers [J]. Clin Chim Acta,2005, 362(1-2):85-93.
[220]Piast M, Kustrzeba-Wojcicka I, Matusiewicz M. Molecular evolution of enolase [J]. Acta Biochim Pol,2005,52(2):507-513.
[221]Fougerousse F, Edom-Vovard F, Merkulova T, et al. The muscle specific enolase is an early marker of human myogenesis [J]. J Muscle Res Cell Motil,2001,22(6):534-544.
[222]Joseph J, Cruz-Sanchez FF, Carreras J. Enolase activity and isoenzyme distribution in human brain regions and tumors [J]. J Neurochem,1996,66(6):2484-90.
[223]Schmechel DE. Gamma-subunit of the glycolytic enzyme enolase:nonspecific or neuron specific? [J] Lab Invest,1985,52(3):239-42.
[224]Rabinowicz AL, Correale JD, Braeht KA, et al.Nerron-specific enolase is increased after nonconvulsive status epileptieus [J]. Epilepsis.1995:36(2):175-479.
[225]Subramanian A, Miller DM. Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene [J]. J Biol Chem,2000,275 (8):5958-5965.
[226]Kinloch A, Tatzer V, Wait R, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis [J]. Arthritis Res Ther,2005,7(6): R1421-1429.
[227]Ren G, Adamus G. Cellular targets of anti-alpha-enolase autoantibodies of patientswith autoimmune retinopathy [J]. J Autoimmun,2004,23(2):161-167.
[228]Nahm DH, Lee KH, Shim JY. Identification of alpha-enolase as an autoantigen associated with severe asthma [J]. J Allergy Clin Immunol,2006,118 (2):376-381.
[229]Chang GC, Liu KJ, Hsieh CL, et al. Identification of alpha-enolase as an autoantigen in lung cancer:its over expression is associated with clinical outcomes [J]. Clin Cancer Res, 2006,12 (19):5746-5754.
[230]Reh G, Nerli B, Pico G. Isolation of alpha-1-antitrypsin from human plasma by partitioning in aqueous biphasic systems of polyethyleneglycol-phosphate [J]. J Chromatogr B Analyt Technol Biomed Life Sci,2002,780(2):389-96.
[231]Layden TJ, Kulik L. Hepatic manifestations of pulmonary diseases [J]. Clin Liver Dis,2002,6(4):969-79.
[231]Lambert N, Freedman RB. Kinetics and specificity of homogeneous protein disulphide-isomerase in protein disulphide isomerization and in thiol-protein-disulphide oxidoreduction [J]. Biochem J,1983,213(1):235-43.
[233]Puig A, Gilbert HF. Anti-chaperone behavior of BiP during the protein disulfide isomerase-catalyzed refolding of reduced and denatured lysozyme [J]. J Biol Chem, 1994,269(41):25889-896.
[234]王志珍.蛋白质二硫键异构酶是酶又是分子伴侣[J].科学通报,1998,43(13)：1345-47.
[2]Nachemson AK. Axons regeneration and growth direction in square-shaped mesothelial chambers [J]. Scand J Plast Reconstr Surg Hand Surg,1988,22:199-206.
[3]Danielsen N, Dahlin LB, Lee YF, Lundborg G. Axonal growth in mesothelial chambers. The role of the distal nerve segment [J]. Scand J Plast Reconstr Surg,1983,17(2):119-25.
[4]Brushart TM, Seiler WA 4th. Selective reinnervation of distal motor stumps by peripheral motor axons [J]. Exp Neurol,1987,97(2):289-300.
[5]罗智捷,卢世璧.神经套接后混合神经中再生的运动和感觉纤维选择性重新支配靶器官[J].中华外科杂志,1996,34(1)：44-46.
[6]Seckel BR, Ryan SE, Gagne RG, et al. Target-specific nerve regeneration through a nerve guide in the rat [J]. Plast Reconstr Surg,1986,78(6):793-800.
[7]Brushart TM, Seiler WA 4th. Selective reinnervation of distal motor stumps by peripheral motor axons [J]. Exp Neurol,1987,97(2):289-300.
[8]Sunderland S. The intraneural topography of the radial, medial and ulnar nerve [J]. Brain, 1945,68(4):243-246.
[9]Sunderland S, Bradley KC. The cross-sectional area of peripheral nerve trunks devoted to nerve fibers [J]. Brain,1949,72(3):428-49.
[10]Jabaley ME, Wallace WH, Heckler FR. Internal topography of major nerves of the forearm and hand:A current view [J]. J Hand Surg Am,1980,5(1):1-18.
[11]Chow JA, Van Beek AL, Bilos ZJ, et al. Anatomical basis for repair of ulnar and median nerves in the distal part of the forearm by group fascicular suture and nerve-grafting [J]. J Bone Joint Surg Am,1986,68(2):273-80.
[12]钟世镇,刘牧之,周长满,等.正中神经的显微外科解剖学研究[J].解剖学报,1980,11：337-339.
[13]周长满.坐骨神经的显微外科解剖学研究[J].解剖学报,1984,15(2)：118-125.
[14]韩震,钟世镇,孙博,等.桡、尺、正中神经的自然分束在临床上的应用[J].中华外科杂志,1986,24：23.
[15]Watchmaker GP, Gumucio GA, Grandall RE, et al. Fascicular to photography of the median nerve:a computer based study to identify branching patterns [J]. J Hand Surg Am, 1991,16(1):53-59.
[16]Hakstian RW. Funicular orientation by direct stimulation, an aid to peripheral nerve repair [J]. J Bone Joint Surg Am,1968,50(6):1178-1186.
[17]Gaul JS Jr. Electrical fascicle identification as an adjunct to nerve repair [J]. J Hand Surg Am,1983,8(3):289-96.
[18]Gaul JS Jr. Electrical fascicle identification as an adjunct to nerve repair [J]. Hand Clin, 1986,2(4):709-22.
[19]朱家恺.周围神经束膜吻合术-探讨有关运动束与感觉束的区别方法[J].中国神经精神疾病杂志,1979,5(5)：229-231.
[20]Vandeput J, Tanner JC, Huypens L. Electro-physiological orientation of the cut ends in primary peripheral nerve repair [J]. Plast Reconstr Surg,1969,44(4):378-82.
[21]贾晓枫,张键,陈统一,等.神经束内微电极采集家兔周围神经电信号的实验研究[J].中华手外科杂志,2002,18(4)：245-247.
[22]Turkof E, Jurasch N, Knolle E, et al. Motor evoked potentials enable differentiation between motor and sensory branches of peripheral nerves in animal experiments [J]. J Reconstr Microsurg,2006,22(7):525-532.
[23]岳喜军,曹晓建,卜寿山,吕天润.近红外光谱和聚类分析法快速鉴别神经束性质的初步研究[J].南京医科大学学报(自然科学版),2006,26(5)：313-317.
[24]王虎,路来金,孔祥贵,刘东听,等.微区喇曼光谱法区分周围神经束性质[J].中国临床康复,2006,10(8)：104-106.
[25]王虎,路来金,刘东昕.周围神经束的快速鉴别[J].中国修复重建外科杂志,2008,22(1)：80-83.
[26]Koelle GB, Friedenwald JA. A histochemical method for localizing cholinesterase activity. Proc Soc Exp Biol Med,1949,70(4):617-22.
[27]Karnovsky MJ, Root L. A"direct-coloring" thiocholine method for cholinestcrase [J]. J histochem Cytochem,1964,12:219-21.
[28]Adams CW, Grant RT, Bayliss OB. Cholinesterases in peripheral nerves system I Mixed, motor and sensory trunks [J]. Brain Res,1967,5(3):366-76.
[29]Gruber H, Zenker W. Acetylcholinesterase:histochemical differentiation between motor and sensory nerve fibres [J]. Brain Reseach,1973,51:207-14.
[30]Gruber H. Identification of motor and sensory funiculi in cut nerves and their selective reunion [J]. Br J Plast Surg,1976,29:70-3.
[31]Freilinger G, Holle J, Sulxgruber SC. Distribution of motor and sensory fibers in the intercostal nerves. Significance in reconstructive surgery [J]. Plast Reconstr Surg,1978,62: 240-4.
[32]何蕴韶,钟世镇.人周围神经内乙酰胆碱酯酶活性与神经束性质的鉴别[J].解剖学报,1987,18(1)：7-11.
[33]Kanaya F. Mixed nerve suture facilitated by enzyme-staining techniques [J]. Tech Hand Up Extrem Surg,2002,6(3):140-4.
[34]Kanaya F, Ogden L, Breidenbach WC, et al. Sensory and motor fiber differentiation with Karnovsky staining [J]. J Hand Surg Am,1991,16(5):851-8.
[35]Deutinger M, Girsch W, Burggassor G, et al.Peripheral nerve repair in the hand with and without motor sensory differentiation [J]. Hand Surg Am,1993,18(3):426-32.
[36]Girsch W, Deutinger M, Bayer GS, et al.Sensorimotor differentiated reconstruction of peripheral nerves--a methods of intraoperative identification of motor fascicles [J]. Handchir Mikrochir Plast Chir,1996,28(4):181-6.
[37]Hansson HP. Histochemical demonstration of carbonic anhydrase activity [J]. Histochemie, 1967,11:112-28.
[38]Riley DA, Lang DH. Carbonic anhydrase activity of human peripheral nerves:a possible histochemical aid to nerve repair [J]. J Hand Surg,1984,9A(1):112-20.
[39]Riley DA, James RS, Sanger JR, et al. Identifying motor and sensory myelinated axons in rabbit peripheral nerves by histochemical staining for carbonic anhydrase and cholinesterase activities [J]. Brain Res.1988,453(1-2):79-88.
[40]周长满,郭海梅.鉴别神经功能束的碳酸酐酶显示法[J].临床应用解剖学杂志,1986,3(3)：148-150.
[41]Carson KA, Tezis JK. Carbonic anhyrace histochemistry. A potential diagnostic method for peripheral nerve repair [J]. Clin Plast Surg,1985,12(2):227-32.
[42]Hattori Y, Doi K, Fukushima S, Kaneko K. The diagnostic value of intraoperative measurement of choline acetyltransferase activity during brachial plexus surgery [J]. J Hand Surg Br,2000,25(5):509-11.
[43]Sanger JR, Riley DA, Matloub HS, et al. Effects of axotomy on the cholinesterase and carbonic anhydrase activities of axons in the proximal and distal stumps of rabbit sciatic nerves:a temporal study [J]. Plast Reconstr Surg,1991,87(4):726-38.
[44]Liu XL, Zhu JK. The histochemical study of rat sciatic nerve cholinesterase in degeneration and regeneration [J]. J Reconstr Microsurg,1990,6(1):43-7.
[45]Engel J, Ganel A, Melamed R, et al. Choline acetyltransferase for differentiation between human motor and sensory nerve fibers [J]. Ann Plast Surg.1980;4(5):376-80.
[46]Ganel A, Farine I, Aharonson Z, et al. Intraoperative nerve fascicle identification using choline acetyltransferase:a preliminary report [J].Clin Orthop Relat Res.1982;(165): 228-32.
[47]Keller A, Margolis FL. Isolation and eliaracterization of rat olfactory marker proteins [J].J Biol Chem,1976,251(20):6232-7.
[48]Norris BJ, Calabrese RL. Identification of motor neutrons that Contain a FMRF amidelike peptide and the effects of FMRFamide on longitudinal muscle in the medicinal leech, Hirudo medicinalis [J]. J comp Neurol,1987,266 (1):95-111.
[49]Borges LF, Iversen SD. Topography of choline acetyltransferase immunoreactive neurons and fibers in the rat spinal cord [J]. Brain Res,1986,362(1):140-8.
[50]Juurlink BH, Munoz DG, Devon RM. Calcitonin gene-related peptide identifies spinal motoneurons in vitro [J]. J Neurosci Res,1990,26(2):238-41.
[51]Hietanen M, Pelto-Huikko M, Rechardt L. Immunocytochemical study of the relations of acetylcholineterase, enkephalin-, substance P-, choline acetyltransferase-and calcitonin gene-related peptide-immunoreactive structures in the ventral horn of rat spinal cord [J].Histochemistry,1990,993(5):473-7.
[52]Urakami H, Chiu AY. A monoclonal antibody that recognizes somatic motor neurons in the mature rat nervous system [J]. J Neurosci,1990,10(2):620-30.
[53]Erkman L, Mattenberger L, Kato AC. A monoclonal antibody distinguishes anterior horn cells of human embryonic spinal cord during a transient period of development [J]. Brain Res Dev Brain Res,1992,66(1):109-17.
[54]Sieber-Blum M. SSEA-1 is a specific marker for the spinal sensory neuron lineage in the quail embryo and in neural crest cell cultures [J]. Dev Biol,1989,134(2):362-75.
[55]Boland LM, Dingledine R. Expression of sensory neuron antigens by a dorsal root ganglion cell line, F-11 [J]. Brain Res Dev Brain Res,1990,51(2):259-66.
[56]严志强,王友华,张沛云,顾晓松.快速免疫组化法区分人周围神经束性质[J].中华显微外科杂志,1996,19(1)：3-5.
[57]XIE jianxun, PU xiaoping, Bao jinfeng, et al. Purification and Identification of a 35 kD Specific Protein (SSP235) of Rat Spinal Sensory Ganglia [J]. Chinese Journal of Biochemistry and Molecular Biology,2001,17(3):306-310.
[58]于昌玉,张咸中,胡玉弘,等.酶联免疫吸附试验技术用于周围神经束定性染色的实验研 究[J].中华手外科杂志,1994,10(3)：176-178.
[59]刘璠,王友华,严志强,等.分子免疫染色法鉴别人体周围神经感觉纤维的实验研究及临床应用[J].中华手外科杂志,1996；12(1)：6-7.
[60]蒲小平,汪家政,顾晓松,范明.兔感觉神经特异蛋白的纯化及稳定性观察[J].生物化学与生物物理进展,1997,24(5)：465-466.
[6l]蒲小平,汪家政,范明,李长龄.脊神经节感觉神经特异蛋白的分离纯化和鉴定[J].生物物理学报,1999,15(2)：315-319.
[62]Matsuda R, Kaneko N, Kikuchi M, et al. Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room [J]. Resuscitation,2003,57(2): 171-7.
[63]Spreca A, Rambotti MG, Giambanco I, et al. Immunocytochemical localization of annexin V (CaBP33), a Ca(2+)-dependent phospholipid-and membrane-binding protein, in the rat nervous system and skeletal muscles and in the porcine heart [J]. J Cell Physiol,1992, 152(3):587-98.
[64]Gotow T, Sakata M, Funakosh T, Uchiyama Y. Preferential localization of annexin V to the axon terminal [J]. Neuroscience,1996,75(2):507-521.
[65]王虎,刘东昕,杜世新.快速组化法快速鉴别周围神经束性质[J].中国现代医生,2008,46(16)：83-85.
[66]Godfrey EW, Nitkin RM, Wallace BG, et al. Components of Torpedo electric organ and muscle that cause aggregation of acetylcholine receptors on cultured muscle cells [J]. J Cell Biol,1984,99(2):615-627.
[67]Burgess RW, Nguyen QT, Son YJ, et al. Alternatively spliced isoforms of nerve-and muscle-derived agrin:their roles at the neuromuscular junction [J]. Neuron,1999,23 (1):33-44.
[68]Ma J, Lugo B, Shah S, et al. Synaptic localization and axonal targeting of agrin secreted by ventral spinal cord neurons in culture [J]. J Neurobiol,2000,15,43(4):338-51.
[69]曾嵘,夏其昌.蛋白质组学研究进展与趋势[J].中国科学院院刊,2002,17(3)：166-169.
[70]Cheung VG, Nowak N, Jang W, et al. Integration of cytogenetic landmarks into the draft sequence of the human genome [J]. Nature,2001,15,409(6822):953-8.
[71]Koonin EV, Wolf YI, Karev GP. The structure of the protein universe and genome evolution [J]. Nature,2002,420(6912):218-23.
[72]Wilkins MR, Sanchez JC, Gooley AA, et al. Progress with proteome projects:why all proteins expressed by a genome should be identified and how to do it [J]. Biotechnol Genet Eng Rev.1996,13:19-50.
[73]de Hoog CL, Mann M. Proteomics [J]. Annu Rev Genomics Hum Genet,2004,5:267-293.
[74]Rappsilber J, Mann M. What does it mean to identify a protein in proteomics [J]. Trends Biochem Sci,2002,27(2):74-78.
[75]Humphery-Smith I, Cordwell SJ, Blackstock WP. Proteome research:complementarity and limitations with respect to the RNA and DNA worlds [J]. Electrophoresis,1997,18(8): 1217-42.
[76]Anderson NL, Anderson NG. Proteome and proteomics:a new technologies, new concepts and new words [J]. Electrophoresis,1998,19(11):1853-61.
[77]Fang X, Balgley BM, Lee CS. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery [J]. Electrophoresis,2009,30(23): 3998-4007.
[78]Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues.A novel approach to testing for induced point mutations in mammals [J]. Humangenetik,1975,26(3):231-43.
[79]O'Farrell PH. High resolution two-dimensional electrophoresis of proteins [J]. J Biol Chem,1975,250 (10):4007-21.
[80]Nilsson CL, Larsson T, Gustafsson E, et al. Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry [J]. Anal Chem,2000,72(9):2148-53.
[81]Fey SJ, Larsen PM.2D or not 2D. Two-dimensional gel electrophoresis [J]. Curr Opin Chem Biol.2001; 5(1):26-33.
[82]Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis:a single gel method for detecting changes in protein extracts [J]. Electrophoresis,1997,18(11):2071-7.
[83]Alban A, David SO, Bjorkesten L, et al. A novel experimental design for comparative two-dimensional gel analysis:two-dimensional difference gel electrophoresis incorporating a pooled internal standard [J]. Proteomics,2003,3(1):36-44.
[84]Van den Bergh G, Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics [J]. Curr Opin Biotechnol,2004,15(1):38-43.
[85]Zhou G, Li H, DeCamp D, et al.2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers [J]. Mol Cell Proteomics,2002, 1(2):117-24.
[86]Yan JX, Devenish AT, Wait R, et al. Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli [J]. Proteomics,2002,2(12):1682-98.
[87]Friedman DB, Hill S, Keller JW, et al. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry [J]. Proteomics, 2004,4(3):793-811.
[88]Costello CE. Bioanalytic applications of mass spectrometry [J]. Curr Opin Biotechnol, 1999,10(1):22-8.
[89]McLafferty FW, Fridriksson EK, Horn DM, et al. Techview:biochemistry. Biomolecule mass spectrometry [J]. Science,1999,284(5418):1289-90.
[90]Han X, Jin M, Breuker K, McLafferty FW. Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons [J]. Science,2006,314(5796):109-112.
[91]Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons [J]. Anal Chem,1988,60(20):2299-2301.
[92]Fenn JB, Mann M, Meng CK, et al. Electrospray ionization for mass spectrometry of large biomolecules [J]. Science,1989,246(4926):64-71.
[93]Pappin DJ, Hojrup P, Bleasby AJ. Rapid identification of proteins by peptide-mass fingerprinting [J]. Curr Biol,1993,3(6):327-332.
[94]Mann M, Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags [J]. Anal Chem,1994,66(24):4390-99.
[95]应万涛,钱小红.生物质谱技术应用及进展[J].军事医学科学院院刊,2000,6(24)：146.
[96]Biemann K. Sequencing of peptides by tandem mass spectrometry and high-energy collision-induced dissociation [J]. Methods Enzymol,1990,193:455-79.
[97]Yates JR 3rd, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database [J]. Anal Chem,1995,67(8):1426-1436.
[98]Hirosawa M, Hoshida M, Ishikawa M, Toya T. MASCOT:multiple alignment system for protein sequences based on three-way dynamic programming [J]. Comput Appl Biosci,1993,9(2):161-167.
[99]Palagi PM, Hernandez P, Walther D, Appel RD. Proteome informatics I:bioinformatics tools for processing experimental data [J]. Proteomics,2006,6(20):5435-44.
[100]Vihinen M. Bioinformatics in proteomics [J]. Biomol Eng,2001,18(2):241-8.
[101]Brown LM, Helmke SM, Hunsucker SW, et al. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue [J]. Mol Carcinog,2006,45(8):613-26.
[102]Gade D, Thiermann J, Markowsky D, Rabus R. Evaluation of two-dimensional difference gel electrophoresis for protein profiling. Soluble proteins of the marine bacterium Pirellula sp. strain 1 [J]. J Mol Microbiol Biotechnol,2003,5(4):240-51.
[103]Hu Y, Wang G, Chen GY, et al. Proteome analysis of Saccharomyces cerevisiae under metal stress by two-dimensional differential gel electrophoresis [J]. Electrophoresis,2003, 24(9):1458-70.
[104]Maeda K, Finnie C, Svensson B:Identification of thioredoxin h-reducible disulphides in proteomes by differential labelling of cysteines:insight into recognition and regulation of proteins in barley seeds by thioredoxin h [J]. Proteomics,2005,5(6):1634-44.
[105]Hoffert JD, van Balkom BW, Chou CL, Knepper MA. Application of difference gel electrophoresis to the identification of inner medullary collecting duct proteins [J]. Am J Physiol Renal Physiol,2004,286(1):F170-9.
[106]Heinemann FS, Korza G, Ozols J. A plasminogen-like protein selectively degrades stearoyl-CoA desaturase in liver microsomes [J]. J Biol Chem,2003,278(44):42966-75.
[107]Anazawa Y, Nakagawa H, Furihara M, et al. PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein ATF-Ibeta/SET [J]. Cancer Res,2005,65(11):4578-86.
[108]Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry [J]. J Proteome Res,2005,4(5):1742-51.
[109]Guest PC, Knowles MR, Molon-Noblot S, et al. Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling [J]. Brain Res,2004,1002(1-2): 1-10.
[110]Cristea IM, Gaskell SJ, Whetton AD. Proteomics techniques and their application to hematology [J]. Blood,2004,103(10):3624-34.
[111]. Somiari RI, Sullivan A, Russell S, et al. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast [J]. Proteomics,2003,3(10):1863-73.
[112]Qualtieri A, Le Pera M, et al. Two-dimensional gel electrophoresis of peripheral nerve proteins:Optimized sample preparation [J]. J Neurosci Methods,2007,159(1):125-33.
[113]Jimenez CR, Stam FJ, Li KW, et al. Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regeneration [J]. Mol Cell Proteomics,2005,4(2): 120-32.
[114]Huang HL, Cendan CM, Roza C, et al. Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves [J]. Mol Pain,2008,12,4:33.
[115]Cho WC. Proteomics technologies and challenges [J]. Genomics Proteomics Bioinformatics,2007,5(2):77-85.
[116]Sunderland S. Nerves and nerve injurues.2nd ed, Edinburgh:Churchill Livingstone,1978.
[117]Becker K, Pan D, Whitely CB. Real-time quantitative polymerase chain reaction to assessgene transfer [J]. Human Gene Ther,1999,10(15):2559-2566.
[118]Shore VG, Shore B. Heterogeneity of human plasma very low density lipoproteins. Separation of species differingin protein components [J]. Bioehemistry,1973,12(3): p.502-7.
[119]Mahley RW. Apolipoprotein E:cholesterol transport protein with expanding role in cell biology [J]. Science.1988,240(4852):622-30.
[120]Ignatius MJ, Shooter EM, Pitas RE, Mahley RW. Lipoprotein uptake by neuronal growth cones in vitro [J]. Science,1987,236(4804):959-62.
[121]Paik YK, Chang DJ, Reardon CA, et al. Nucleotide sequence and structure of the human apolipoprotein E gene [J]. Proc Natl Acad Sci U S A,1985,82(10):3445-9.
[122]Breslow JL. Transgenic mouse models of lipoprotein metabolism and atherosclerosis [J]. Proc Natl Acad Sci U S A,1993,90(18):8314-8.
[123]Wetterau JR, Aggerbeck LP, Rall SC Jr, Weisgraber KH. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains [J]. J Biol Chem,1988, 263(13):6240-8.
[124]Masliah E, Mallory M, Veinbergs I, et al. Alterations in apolipoprotein E expression during aging and neurodegeneration [J]. Prog Neurobiol,1996,50(5-6):493-503.
[125]Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease [J]. Lancet,1993,342(8873):697-9.
[126]Weisgraber KH, Roses AD, Strittmatter WJ. The role of apolipoprotein E in the nervous system [J]. Curr Opin Lipidol,1994,5(2):110-6.
[127]Mahley RW, Rall SC Jr. Apolipoprotein E:far more than a lipid transport protein [J]. Annu Rev Genomics Hum Genet,2000; 1:507-37.
[128]Han SH, Einstein G, Weisgraber KH, et al. Apolipoprotein E is localized to the cytoplasm of human cortical neurons:a light and electron microscopic study [J]. J Neuropathol Exp Neurol,1994,53(5):535-44.
[129]Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve [J]. J Clin Invest,1989,83(3):1015-31.
[130]Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease [J]. Trends Neurosci,1994,17(12):525-30.
[131]Sparks DL, Liu H, Gross DR, Scheff SW. Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol [J]. Neurosci Lett,1995,187(2):142-4.
[132]Avila EM,Holdsworth QSasaki N,et al. Apoprotein E suppresses phytohemagglutiriin-activated phospholipid turnover in peripheral blood mononuclear cells [J]. J Biol Chem,1982,257(10):5900-9.
[133]Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice [J]. Circulation,2001, 104(2):197-202.
[134]Yu S, Duan RS, Chen Z, et al. Increased susceptibility to experimental autoimmune neuritis after upregulation of the autoreactive T cell response to peripheral myelin antigen in apolipoprotein E-deficient mice [J]. J Neuropathol Exp Neurol,2004,63(2):120-8.
[135]Gaillard O, Gervais A, Meillet D, et al. Apolipoprotein E and multiple sclerosis:a biochemical and genetic investigation [J]. J Neurol Sci,1998,158(2):180-6.
[136]Larner AJ, Johnson AR, Keynes RJ. Regenertion in the vertebrate central nervous system: phylogeny, ontnoeny, and mechanisms [J]. Biol Rev,1995,70(4):597-619.
[137]Schwab ME, Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord [J]. Physiol Rev,1996,76(2):319-370.
[138]Mullins FH, Hargreaves AJ, Li JY, et al. Tyrosination state of alpha-tubulin in regenerating peripheral nerve [J]. J Neurochem,1994,62(1):227-34.
[139]Scott D, Smith KE, O'Bhen BJ, et al. Characterization of mammalian neurofilament triplet proteins [J]. J Biol Chem,1985,260(19):10736-10747.
[140]Fliegner KH, Liem RK. Cellular and molecular biology of neuronal intermediate filaments [J]. Int Rev Cytol,1991,131:109-67.
[141]Hisanaga S, Ikai A, Hirokawa N. Molecular architecture of the neurofilament. I. Subunit arrangement of neurofilament L protein in the intermediate-sized filament [J]. J Mol Biol,1990,211(4):857-69.
[142]Hisanaga S, Hirokawa N. Molecular architecture of the neurofilament. Ⅱ. Reassembly process of neurofilament L protein in vitro [J]. J Mol Biol,1990,211(4):871-82.
[143]Hirokawa N. Cross-linker system between neurofilaments, microtubules, and membranous organelles in frog axons revealed by the quick-freeze, deep-etching method [J]. J Cell Biol,1982,94(1):129-42.
[144]Elder GA, Friedrich VL Jr, Bosco P, et al. Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content [J]. J Cell Biol,1998,141(3):727-39.
[145]Zhu Q, Couillard-Despres S, Julien JP. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments [J]. Exp Neurol,1997,148(1):299-316.
[146]Yabe J T, Wang F S, Chylinski T, et al. Selective accumulation of the high molecular weight neurofilament subunit within the distal region of growing axonal neuritis [J]. Cell Motil Cytoskeleton,2001,50(1):1-12.
[147]Uchida A, Brown A. Arrival, reversal, and departure of neurofilament at the tip s of growing axons [J]. Mol Biol Cell,2004,15(9):4215-4225.
[148]Uchida K, Baba H, Maczawa Y, et al. Progressive changes in neurofilament p roteins and growth associated p rotein-4 3 immunoreactivities at the site of cervical spinal cord compression in spinal hyerostotic mice [J]. Spine,2002,27(5):480-487.
[149]Miller FD, Tetzlaff N, Bisby MA, et al. Rapid induction of major embryonica-tubulin during nerve regeneration in adult rats [J]. J Neurosci,1989,9(4):1452-63.
[150]Gan SD, Fan M, He GP. The role of microtubule in axoplasmia transport in vivo [J].Brain Res,1986,369 (122):75-82.
[151]Mitchison T, Kirschner M. Cytoskeletal dynamics and nerve growth [J]. Neuron,1988,1 (9):761-72.
[152]Oblinger MM, Argasinski A, Wong J, et al. The gene expression in rat sensory neurons during development and regeneration [J]. J Neurosci,1991,11(8):2453-59.
[153]米瑞发,周长满,范明.大鼠坐骨神经损伤后背根节感觉神经元神经丝蛋白基因表达的变化[J].解剖学报,2001,32(4)：324-328.
[154]Miller CC, Ackerley S, Brownlees J, et al. Axonal transport of neurofilaments in normal and disease states[J].Cell Mol Life Sci,2002;59(2):323-330.
[155]Bajo M, Yoo BC, Cairns N, et al. Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease [J]. Amino Acids,2001, 21(3):293-301.
[156]Nakamura Y, Hasimoto R, Kashiwagi Y, et al. Abnormal distribution of neurofilament L in neurons with Alzheimer's disease [J]. Neurosci Lett,1997,225(3):201-4.
[157]Lee MK, Cleveland DW. Neuronal intermediate filaments [J]. Annu Rev Neurosci,1996, 19:187-17.
[158]Kane LP,Watkins SC.Dynamic regulation of Tec kinase localization in membrane-proximal vesicles of a T cell clone revealed by total internal reflection fluorescence and confocal microscopy [J]. J Biol Chem,2005,280(23):21949-54.
[159]Takesono A, Finkelstein LD, Schwartzberg PL. Beyond calcium:new signaling pathways for Tec family kinases [J]. J Cell Sci,2002,115(Pt 15):3039-48.
[160]Mano H, Ishikawa F, Nishida J, et al. A novel protein-tyro sine kinase, tec, is preferentially expressed in liver [J]. Oncogene,1990,5(12):1781-6.
[161]Xu W, Wang S, Wang G, et al. Identification and characterization of differentially expressed genes in the early response phase during liver regeneration [J]. Biochem Biophys Res Commun,2000,278(2):318-25.
[162]Fruman DA, Snapper SB, Yballe CM, et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha [J]. Science,1999, 283(5400):393-7.
[163]Suzuki H, Terauchi Y, Fujiwara M, et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase [J]. Science,1999, 283(5400):390-2.
[164]Bolen JB. Nonreceptor tyrosine protein kinases [J]. Oncogene,1993,8(8):2025-31.
[165]Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL. Tec family kinases in T lymphocyte development and function [J]. Annu Rev Immunol,2005;23:549-600.
[166]Finkelstein LD, Shimizu Y, Schwartzberg PL, et al. Tec kinases regulate TCR-mediated recruitment of signaling molecules and integrin-dependent cell adhesion [J]. J Immunol,2005,175(9):5923-30.
[167]Finkelstein LD, Schwartzberg PL. Tec kinases:shaping T-cell activation through actin [J]. Trends in Cell Biology,2004,14(8):443-451.
[168]Qin Y, Kung HJ. Signaling network of the Btk family kinases [J]. Oncogene, 2000,19(49):5651-5661.
[169]Hastings GA, Colemna TA, Haudenschild CC, et al. Neuroseprin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons [J]. J Biol Chem,1997;272(52):33062-7.
[170]Sipione S, Simmen KC, Lord SJ, et al. Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cells [J]. J Immunol,2006,177(8):5051-5058.
[171]Docagne F, Nicole O, Marti HH, et al. Transforming growth factor-betal as a regulator of the serpins/t-PA axis in cerebral ischemia [J]. FASEB J,1999,13(11):1315-24.
[172]Yepes M, Sandkvist M, Coleman TA, et al. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent [J]. J Clin Invest,2002,109(12):1571-1578.
[173]Simonin Y, Charron Y, Sonderegger P, et al. An inhibitor of serine proteases, neuroserpin, acts as a neuroprotective agent in a mouse model of neurodegenerative disease [J]. Journal of Neuroseienee,2006,26(41):10614-10619.
[174]Groot DM, Martens GJ. Expression of neuroserpin is linked to neuroendoerine cell activation [J]. Endocrinology,2005,146(9):3791-3799.
[175]Galliciotti G, Sonderegger P. Neuroserpin [J]. Frontiers in Bioscience,2006,11:33-45.
[176]Wang X, Phelan SA, Forsman-Semb K, et al. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress [J]. J Biol Chem,2003,278(27):25179-90.
[177]Rabilloud T, Heller M, Gasnier F, et al. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site [J]. J Biol Chem,2002,277(22):19396-401.
[178]Crowley-Weber CL, Payne CM, G leason-Guzman M, et al. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate [J]. Carcinogenesis,2002,23(12):2063-80.
[179]Somiari R1, Sullivan A, Russell S, et al. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast [J]. Proteomics,2003,3(10):1863-73.
[180]Park SY, Yu X, Ip C, et al. Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation [J]. Cancer Res,2007,67(19):9294-9303.
[181]Donnelly S, Stack CM, O'Neill SM, et al. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages [J]. FASEB J,2008,22(11):4022-32.
[182]Kang SW, Chang TS, Lee TH, et al. Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-alpha [J]. J Biol Chem,2004,279(4):2535-43.
[183]Makino Y, Okamoto K, Yoshikawa N, et al. Thioredoxin:a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system [J]. J Clin Invest,1996,98(11):2469-77.
[184]Bharadwa JS, prasad GL. Tropomyosin-1, a novel suppressor of cellular transformation is down regulated by promoter methylation in cancer cells [J]. Cancer Lett,2002, 183(2):205-213.
[185]Perry SV. Vertebrate tropomyosin:distribution, properties and function [J]. J Muscle Res Cell Motil,2001,22(1):5-49.
[186]Pittenger MF, Kazzaz JA, Helfman DM. Functional properties of non-muscle tropomyosin isoforms [J]. Curr Opin Cell Biol,1994,6(1):96-104.
[187]Mahadev K, Raval G, Bharadwaj S, et al. Suppression of the transformed phenotype of breast cancer by tropomyosin [J]. Exp Cell Res,2002,279(l):40-51.
[188]Raval GN, Bharadwaj S, Levine EA, et al. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors [J].Oncogene, 2003,22(40):6194-6203.
[189]Franzen B, Linder S, Uryu K, et al. Expression of tropomyosin isoforms in benign and malignant human breast lesions [J]. Br J Cancer,1996,73(7):909-913.
[190]Nakata K, Ujike H, Sakai A, et al. The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia [J]. Biol Psychiatry,2003,53(7):571-6.
[191]Zhao X, Tang R, Xiao Z, et al. An investigation of the dihydropyrimidinase-like 2(DPYSLZ) gene in schizophrenia:genetic association study and expression analysis [J]. Int J Neuropsychopharmacol,2006,9(6):705-712.
[192]Nishimura T, Fukata Y Kato K, et al. CRMP-2 regulates polarized Numbmediated endocytosis for axon growth [J]. Nat Cell Biol,2003,5(9):819-26.
[193]Weitzdoerfer R, Fountoulakis M, Lubec G. Aberrant expression of dihydropyrimidinase related proteins-2,-3 and-4 in fetal Down syndrome brain [J]. J Neural Transm Suppl,2001,(61):95-107.
[194]Vincent P, Collette Y, Marignier R, et al. A role for the neuronal protein collapsing response. mediator protein 2 in T lymphocyte polarization and migration [J]. J Immunol,2005,175(11):7650-60.
[195]Chung MA, Lee JE, Lee JY, et al. Alteration of collapsing response mediator protein-2 expression in focal ischemic rat brain [J]. Neuroreport,2005,16(15):1647-53.
[196]Peter F, Nguyen Van P, Soling HD. Different sorting of Lys-Asp-Glu-Leu proteins in rat liver [J]. J Biol Chem,1992,267(15):10631-7.
[197]Ellgaard L, Ruddock LW. The human protein disulphide isomerase family:substrate interactions and functional properties [J]. EMBO Rep,2005,6(1):28-32.
[198]Seidenbecher CI, Landwehr M, Smalla KH, et al. Caldendrin but not calmodulin binds to light chain 3 of MAP1A/B:an association with the microtubule cytoskeleton highlighting exclusive binding partners for neuronal Ca(2+)-sensor proteins [J]. J Mol Biol, 2004,336(4):957-70.
[199]Wingard JN, Chan J, Bosanac I, et al. Structural analysis of Mg2+and Ca2+binding to CaBPl, a neuron-specific regulator of calcium channels [J]. J Biol Chem,2005, 280(45):37461-70.
[200]Haynes LP, Tepikin AV, Burgoyne RD. Calcium-binding protein 1 is an inhibitor of agonist-evoked, inositol 1,4,5-trisphosphate-mediated calcium signaling [J]. J Biol Chem,2004,279(1):547-55.
[201]German DC, Manaye KF, Sonsalla PK, Brooks BA. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism:sparing of calbindin-D28k-containing cells [J]. Ann N Y Acad Sci,1992,648:42-62.
[202]胡轶虹,常明,张瑜,等.PSI诱导的PC12细胞胞浆内胞核旁嗜酸性包涵体的形成及演变过程[J].中风与神经疾病杂志,2007,24：20-22.
[203]Nishi S, Taki W, Uemura Y, et al. Ischemic tolerance due to the induction of HSP70 in a rat ischemic recirculation model [J]. Brain Res,1993,615(2):281-8.
[204]Pasqualini R, Bourdoulous S, Koivunen E, et al. A polymeric form of fibronectin has antimetastatic effects against multiple tumor types [J]. Nat Med,1996,2(11):1197-203.
[205]Suzuki T, Usuda N, Murata S, et al. Presence of molecular chaperones, heat shock cognate (Hsc) 70 and heat shock proteins (Hsp) 40, in the postsynaptic structures of rat brain [J]. Brain Res,1999,16;816(1):99-110.
[206]Kinouchi H, Sharp FR, Koistinaho J, et al. Induction of heat shock hsp70 mRNA and HSP70 KDa protein in neurons in the'penumbra' following focal cerebral ischemia in the rat [J]. Brain Res,1993,619 (1-2):334-338.
[207]Kato H, Kogure K. Boichemical and molecular characteristic of the brain with developing cerebral infarction [J]. Cell Mol Neurobiol,1999,19 (1):93-96.
[208]Tobaber S, Thakur P, Fernandez-Chacon K, et al. A trimeric protein complex functions as a synaptic chaperone machine [J].Neuron,2001,31(6):987-999.
[209]Isomoto H, Oka M, Yano Y, et al. Expression of heat shock protein (Hsp)70 and Hsp 40 in gastric cancer [J].Cancer Lett,2003,198(2):219-228.
[210]Aghdassi A, Phillips P, Dudeja V, et al. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma [J]. Cancer Res,2007,67(2):616-625.
[211]Xiong Ren Ping, Liu Ping,Zhou Yuan Guo, et al. Extraction of trace total RNA and protein from small quantity cultured cells [J]. Chin J Biochem Mol Biol,2003, 19(2):256-260.
[212]Schwacha MG, Somers SD. Thermal injury induces macrophage hyperactivity through pertussis toxin-sensitive and-insensitive pathways [J]. Shock,1998,9(4):249-55
[213]Grant KR, Harnett W, Milligan G, Harnett MM. Differential G-protein expression during B-and T-cell development [J]. Immunology,1997,90(4):564-71.
[214]Dairaghi DJ, Soo KS, Oldham ER, et al. RANTES-induced T cell activation correlates with CD3 expression [J]. J Immunol,1998,160(1):426-33.
[215]Griguer CE, Oliva CR, Gillespie GY. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines [J]. J Neurooncol,2005,74(2):123-33.
[216]Liu ZJ, Peng WC, Yang X, et al. Relative mRNA expression of the lactate dehydrogenase A and B subunits as determined by simultaneous amplification and single strand conformation polymorphism.Relation with subunit enzyme activity [J]. J Chromatogr B Analyt Technol Biomed Life Sci,2003,793(2):405-412.
[217]Sudo K, Maekawa M, Houki N, et al. A novel in-frame deletion mutation in a case of lactate dehydrogenase (LD)H subunit deficiency showing an atypical LD isoenzyme pattern in serum and erythrocytes [J].Clin Biochem,1999,32(2):137-141.
[218]Chen Y, Zhang H, Xu A, et al. Elevation of serum 1-lactate dehydrogenase B correlated with the clinical stage of lung cancer [J].Lung Cancer,2006,54(l):95-102.
[219]Santonocito C, Concolino P, Lavieri MM, et al. Comparison between three molecular methods for detection of blood melanoma tyrosinase mRNA. Correlation with melanoma stages and S100B, LDH, NSE biochemical markers [J]. Clin Chim Acta,2005, 362(1-2):85-93.
[220]Piast M, Kustrzeba-Wojcicka I, Matusiewicz M. Molecular evolution of enolase [J]. Acta Biochim Pol,2005,52(2):507-513.
[221]Fougerousse F, Edom-Vovard F, Merkulova T, et al. The muscle specific enolase is an early marker of human myogenesis [J]. J Muscle Res Cell Motil,2001,22(6):534-544.
[222]Joseph J, Cruz-Sanchez FF, Carreras J. Enolase activity and isoenzyme distribution in human brain regions and tumors [J]. J Neurochem,1996,66(6):2484-90.
[223]Schmechel DE. Gamma-subunit of the glycolytic enzyme enolase:nonspecific or neuron specific? [J] Lab Invest,1985,52(3):239-42.
[224]Rabinowicz AL, Correale JD, Braeht KA, et al.Nerron-specific enolase is increased after nonconvulsive status epileptieus [J]. Epilepsis.1995:36(2):175-479.
[225]Subramanian A, Miller DM. Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene [J]. J Biol Chem,2000,275 (8):5958-5965.
[226]Kinloch A, Tatzer V, Wait R, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis [J]. Arthritis Res Ther,2005,7(6): R1421-1429.
[227]Ren G, Adamus G. Cellular targets of anti-alpha-enolase autoantibodies of patientswith autoimmune retinopathy [J]. J Autoimmun,2004,23(2):161-167.
[228]Nahm DH, Lee KH, Shim JY. Identification of alpha-enolase as an autoantigen associated with severe asthma [J]. J Allergy Clin Immunol,2006,118 (2):376-381.
[229]Chang GC, Liu KJ, Hsieh CL, et al. Identification of alpha-enolase as an autoantigen in lung cancer:its over expression is associated with clinical outcomes [J]. Clin Cancer Res, 2006,12 (19):5746-5754.
[230]Reh G, Nerli B, Pico G. Isolation of alpha-1-antitrypsin from human plasma by partitioning in aqueous biphasic systems of polyethyleneglycol-phosphate [J]. J Chromatogr B Analyt Technol Biomed Life Sci,2002,780(2):389-96.
[231]Layden TJ, Kulik L. Hepatic manifestations of pulmonary diseases [J]. Clin Liver Dis,2002,6(4):969-79.
[231]Lambert N, Freedman RB. Kinetics and specificity of homogeneous protein disulphide-isomerase in protein disulphide isomerization and in thiol-protein-disulphide oxidoreduction [J]. Biochem J,1983,213(1):235-43.
[233]Puig A, Gilbert HF. Anti-chaperone behavior of BiP during the protein disulfide isomerase-catalyzed refolding of reduced and denatured lysozyme [J]. J Biol Chem, 1994,269(41):25889-896.
[234]王志珍.蛋白质二硫键异构酶是酶又是分子伴侣[J].科学通报,1998,43(13)：1345-47.